Citation	Subject	Subject Label	Predicate	Object	Object Label	Qualifier	Subject Qualifier	Subject Extension	Object Extension	Count
31113589	MAXO:0001175	liver transplantation	TREATS	HP:0006554	Acute Liver Failure	MONDO:0010200				2
28433103	MAXO:0001175	liver transplantation	TREATS	HP:0006554	Acute Liver Failure	MONDO:0010200				2
31421978	MAXO:0000376	liver biopsy	TREATS	HP:0001394	Cirrhosis	MONDO:0010200				2
28433112	MAXO:0000376	liver biopsy	TREATS	HP:0001394	Cirrhosis	MONDO:0010200				2
31421978	MAXO:0000376	liver biopsy	TREATS	HP:0006554	Acute Liver Failure	MONDO:0010200				2
28433112	MAXO:0000376	liver biopsy	TREATS	HP:0006554	Acute Liver Failure	MONDO:0010200				2
28987261	Diagnosis		TREATS	Wilson Disease						1
28987261	MAXO:0000376	liver biopsy	TREATS	Wilson Disease						1
28987261	MAXO:0000533	Molecular genetic testing	TREATS	Wilson Disease						1
28987261	Medical therapy		TREATS	Wilson Disease						1
28987261	Liver transplant		TREATS	Acute liver failure		Wilson Disease				1
28987261	Liver transplant		TREATS	Advanced liver disease		MONDO:0010200				1
28987261	Treatment monitoring		TREATS	Wilson Disease						1
28987261	Clinical evaluation		TREATS	Wilson Disease						1
28987261	Liver tests		TREATS	Wilson Disease						1
28987261	Blood counts		TREATS	Wilson Disease						1
29759592	CDG screening		TREATS	early and severe liver fibrosis		MONDO:0014789		CDG screening		1
29759592	CDG screening		TREATS	HP:0001394	Cirrhosis	MONDO:0014789				1
29759592	CDG screening		TREATS	neurological symptoms		MONDO:0014789				1
29759592	CDG screening		TREATS	isolated and late severe liver involvement		CCDC115-CDG		CDG screening		1
29759592	CDG screening		TREATS	HP:0003124	hypercholesterolemia	MONDO:0014789				1
29759592	CDG screening		TREATS	elevated alkaline phosphatases		CCDC115-CDG		CDG screening	elevated alkaline phosphatases	1
29759592	CDG screening		TREATS	defects in copper metabolism		CCDC115-CDG		CDG screening		1
29759592	glycosylation study		TREATS	liver fibrosis		CCDC115-CDG		glycosylation study	early and severe	1
29759592	glycosylation study		TREATS	HP:0001394	Cirrhosis	MONDO:0014789				1
29759592	glycosylation study		TREATS	neurological symptoms		MONDO:0014789		glycosylation study		1
29759592	glycosylation study		TREATS	isolated and late severe liver involvement		MONDO:0014789		glycosylation study		1
29759592	glycosylation study		TREATS	HP:0003124	hypercholesterolemia	MONDO:0014789		glycosylation study		1
29759592	glycosylation study		TREATS	HP:0003155	elevated alkaline phosphatases	MONDO:0014789		glycosylation study		1
29759592	glycosylation study		TREATS	defects in copper metabolism		MONDO:0014789		glycosylation study		1
31611120	Splenectomy with distal pancreatectomy		TREATS	giant splenic artery aneurysms		MONDO:0010200				1
31611120	Living donor liver transplantation		TREATS	decompensated liver cirrhosis		MONDO:0010200				1
31611120	Emergency interventional radiology		TREATS	postoperative rupture of the aneurysm in the left renal artery		Wilson Disease				1
28836933	Decompressive craniotomy		TREATS	HP:0001342	Intracerebral hemorrhage	MONDO:0013792				1
28836933	Hematoma drainage		TREATS	HP:0001342	Intracerebral hemorrhage	MONDO:0013792				1
28836933	Catheter placement		TREATS	HP:0001342	Intracerebral hemorrhage	MONDO:0013792				1
28836933	Cranial magnetic resonance imaging		IDENTIFIES	Lesions consistent with embolic infarction		MONDO:0013792				1
28836933	Computerized tomography examinations		IDENTIFIES	Intracerebral hemorrhage		Intracerebral Hemorrhage		Computerized tomography examinations		1
33547549	Diagnosis		TREATS	Copper accumulation in the brain and liver		MONDO:0010200		artificial intelligence		1
33547549	Diagnosis		TREATS	HP:0030890	White matter hyperintensity	MONDO:0010200		artificial intelligence		1
31113589	treatment		TREATS	hyperacute liver failure		MONDO:0010200	none	CHEBI:7959	none	1
31113589	treatment		TREATS	HP:0006554	Acute Liver Failure	MONDO:0010200		CHEBI:7959		1
31113589	MAXO:0001175	liver transplantation	TREATS	hyperacute liver failure		MONDO:0010200				1
31113589	Prometheus therapy		TREATS	HP:0006554	Acute Liver Failure	MONDO:0010200		Prometheus therapy		1
30452922	activation of autophagy		TREATS	apoptosis		MONDO:0010200		spautin-1	copper-induced	1
30452922	pharmacologic inhibitors		PREVENTS	autophagy activation		MONDO:0010200		pharmacologic inhibitors of autophagy	autophagy activation	1
30452922	knockdown		PREVENTS	autophagy activation		MONDO:0010200	autophagy proteins	ATG7 and ATG13	autophagy activation	1
30452922	RNA-seq		DETECTS	gene expression changes		MONDO:0010200				1
30452922	spectroscopy		DETECTS	copper accumulation		MONDO:0010200				1
35443488	MAXO:0000376	Liver biopsy	TREATS	HP:0001395	Liver fibrosis	MONDO:0013209				1
35443488	Ultrasound abdomen		TREATS	HP:0001395	Liver fibrosis	MONDO:0013209				1
35443488	Novel Fibrosis Index (NFI) calculation		TREATS	Liver fibrosis		MONDO:0013209		Novel Fibrosis Index calculation		1
35443488	Fibroscan		TREATS	Liver fibrosis		MONDO:0013209		402 fibrosis stage assessment		1
35443488	Transient elastography		TREATS	HP:0001395	Liver fibrosis	MONDO:0013209				1
35443488	Use of ROC curves		TREATS	HP:0001395	Liver fibrosis	MONDO:0013209		ROC curves		1
31167735	MAXO:0000376	liver biopsy	TREATS	Metastatic cholangiocarcinoma		patient				1
28578978	Treatment with d-penicillamine		TREATS	Wilson disease						1
28578978	Treatment		TREATS	Wilson disease				CHEBI:27363		1
28578978	Treatment		TREATS	Wilson disease			with	CHEBI:39501		1
28578978	MAXO:0001175	liver transplantation	TREATS	HP:0001399	Liver failure	MONDO:0010200				1
30691663	Brain magnetic resonance spectroscopy		DETECTS	increased signal intensity in the basal ganglia		MONDO:0010200				1
30691663	Examination		DETECTS	early neurological changes		Wilson's disease		1.5 T MRI scanner		1
30691663	Measurement of N-acetyl aspartate, choline, and creatine spectra		DETECTS	significant decrease in NAA, Cho, Cr		MONDO:0010200		N-acetyl aspartate, Choline, Creatine	significant decrease in NAA, Cho, Cr	1
30691663	Comparison of metabolite ratios		DETECTS	significant decrease in metabolite ratios		Wilson's disease		metabolite ratios (NAA/Cho, NAA/Cr, Cho/Cr)		1
31077787	use for lens densitometry		TREATS	increased lens densitometry values		MONDO:0010200		Pentacam HR imaging system		1
31077787	use for corneal densitometry		TREATS	increased corneal densitometry values		MONDO:0010200		Pentacam HR imaging system		1
31077787	copper accumulation		PREVENTS	decreased corneal and lens clarity		MONDO:0010200				1
31582009	Initial Lab Testing		TREATS	HP:0008282	Indirect hyperbilirubinemia	MONDO:0005154				1
31582009	Initial Lab Testing		TREATS	HP:0002088	Lung disease	MONDO:0005154				1
31582009	Initial Lab Testing		TREATS	Neurologic disease		MONDO:0005154				1
31582009	Initial Lab Testing		TREATS	HP:0001396	Cholestasis	MONDO:0005154				1
31582009	Management		TREATS	HP:0008282	Indirect hyperbilirubinemia	MONDO:0005154				1
31582009	Management		TREATS	HP:0002088	Lung disease	MONDO:0005154				1
31582009	Management		TREATS	Neurologic disease		MONDO:0005154				1
31582009	Management		TREATS	HP:0001396	Cholestasis	MONDO:0005154				1
34934154	Metallothionein immunohistochemistry		TREATS	protean clinical presentations		MONDO:0010200				1
34934154	copper staining		TREATS	protean clinical presentations		MONDO:0010200		copper staining		1
34934154	quantitative copper assays		TREATS	protean clinical presentations		MONDO:0010200	quantitative	copper assays		1
30028785	Diagnosis of ALF-CLD		TREATS	Raised transaminases		Chronic Liver Disease presenting as Acute Liver Failure in Childhood				1
30028785	Diagnosis of ALF-CLD		TREATS	International Normal Ratio >=2.0		Chronic Liver Disease presenting as Acute Liver Failure in Childhood				1
30028785	Diagnosis of ALF-CLD		TREATS	HP:0001744	Splenomegaly	Chronic Liver Disease presenting as Acute Liver Failure in Childhood				1
30028785	Diagnosis of ALF-CLD		TREATS	HP:0001541	Ascites	Chronic Liver Disease presenting as Acute Liver Failure in Childhood				1
30028785	Diagnosis of ALF-CLD		TREATS	Cirrhosis		Chronic Liver Disease				1
30028785	OVERDOSE		TREATS	HP:0006554	Acute Liver Failure	Chronic Liver Disease		CHEBI:46195		1
36872503	transcranial magnetic stimulation		TREATS	HP:0012896	abnormal motor evoked potentials (MEPs)	MONDO:0010200				1
36872503	treatment introduction		TREATS	HP:0012896	abnormal motor evoked potentials (MEPs)	MONDO:0010200		CHEBI:35176		1
37121747	family screening tests		PREVENTS	persistent liver dysfunction		Wilson Disease				1
37121747	annual medical checkup		PREVENTS	HP:0001410	liver dysfunction	MONDO:0010200				1
37121747	MAXO:0000376	Liver biopsy	TREATS	HP:0001410	liver dysfunction	MONDO:0010200				1
37121747	MAXO:0000127	Genetic testing	TREATS	HP:0001410	liver dysfunction	MONDO:0010200				1
37121747	chelation therapy		TREATS	HP:0001397	Liver steatosis	MONDO:0010200				1
34666712	Treatment		TREATS	abnormal copper metabolism		MONDO:0010200	oral	CHEBI:50868		1
34666712	MAXO:0001298	therapy	TREATS	abnormal copper metabolism		MONDO:0010200		CHEBI:35176		1
34666712	MAXO:0001298	therapy	TREATS	nephritis-range proteinuria		MONDO:0010200		CHEBI:6541		1
34666712	Treatment		TREATS	HP:0001394	Cirrhosis	MONDO:0010200	oral	CHEBI:50868		1
32539308	Multigene Panel Testing		PREVENTS	Late Diagnosis		Wilson Disease		Multigene Panel Testing		1
37226184	diagnosis		TREATS	symptoms and manifestations		MONDO:0010200		Leipzig score algorithm	variable	1
37226184	routine monitoring biannually		PREVENTS	worsening of variable symptoms and manifestations		MONDO:0010200				1
37226184	MAXO:0001175	liver transplantation	TREATS	severe cases		MONDO:0010200				1
29325287	Diagnostic scoring system		ASSESSES	Wilson's disease						1
29325287	Liver function tests		DETECT	chronic liver disease signs		MONDO:0010200				1
29325287	Coombs-negative hemolytic anemia diagnosis		DETECTS	HP:0001878	hemolytic anemia	MONDO:0010200				1
29325287	MAXO:0001181	Serum alkaline phosphatase measurement	DETECTS	subnormal serum alkaline phosphatase		MONDO:0010200				1
29325287	Kayser-Fleischer rings observation		IDENTIFIES	HP:0200032	Kayser-Fleischer rings	MONDO:0010200				1
29325287	Serum ceruloplasmin level measurement		DETECTS	low serum ceruloplasmin level		Wilson's disease		ceruloplasmin	ceruloplasmin	1
29325287	24-hour urinary copper excretion test		DETECTS	high 24-hour urinary copper excretion		MONDO:0010200				1
29325287	Penicillamine challenge test		DETECTS	urinary copper excretion		MONDO:0010200	with Penicillamine	CHEBI:50868	high	1
29325287	Hepatic copper determination		DETECTS	Wilson's disease						1
29325287	Direct complete DNA sequencing		IDENTIFIES	mutations		Wilson's disease		DNA sequencing	mutations	1
34857647	Chelation		TREATS	copper toxicity		MONDO:0010200				1
34857647	Copper affinity		PREVENTS	Blood-brain barrier damage		MONDO:0010200	with ALXN1840	ALXN1840		1
34857647	Protein embedding		PREVENTS	Blood-brain barrier damage		MONDO:0010200	with ALXN1840	ALXN1840		1
34857647	Mitochondrial protection		PREVENTS	Blood-brain barrier damage		MONDO:0010200		Mitochondrial protection		1
34857647	Chelation		TREATS	copper toxicity		MONDO:0010200	with DPA	CHEBI:34936		1
34857647	Chelation		PREVENTS	Neurological deterioration		MONDO:0010200	with ALXN1840	ALXN1840		1
37491953	Withdrawal of metal chelating agent therapy		TREATS	Aggravation of clinical symptoms		MONDO:0010200		metal chelating agent		1
37491953	Treatment		TREATS	Neurological symptoms aggravation		MONDO:0010200		metal chelating agent		1
37491953	Treatment		TREATS	Increased liver injury		MONDO:0010200		metal chelating agent		1
37491953	Treatment		TREATS	Increased metal deposition		MONDO:0010200	with Metal chelating agent	Metal chelating agent		1
37491953	Treatment with metal chelating agent		TREATS	New nerve injury		MONDO:0010200		Metal chelating agent		1
32485301	Biochemical assays		TREATS	hepatic features		MONDO:0010200	with ceruloplasmin	ceruloplasmin		1
32485301	Biochemical assays		TREATS	neurologic features		MONDO:0010200	with copper	CHEBI:28694		1
32485301	diagnosis		TREATS	neurologic features		Wilson's disease		Kayser-Fleischer rings		1
32485301	MAXO:0000127	Genetic testing	TREATS	hepatic features		MONDO:0010200				1
32485301	MAXO:0000127	Genetic testing	TREATS	neurologic features		MONDO:0010200				1
32485301	MAXO:0000127	Genetic testing	TREATS	osteomuscular features		MONDO:0010200				1
32485301	MAXO:0000127	Genetic testing	TREATS	psychiatric symptoms		MONDO:0010200				1
32485301	serum level of ceruloplasmin measurement		TREATS	hepatic features		MONDO:0010200				1
32485301	serum level of ceruloplasmin measurement		TREATS	neurologic features		MONDO:0010200		ceruloplasmin		1
32485301	24-hour urinary copper excretion measurement		TREATS	hepatic features		MONDO:0010200				1
32485301	24-hour urinary copper excretion measurement		TREATS	neurologic features		Wilson's disease		24-hour urinary copper excretion measurement		1
32485301	MRI		TREATS	neurologic features		MONDO:0010200				1
33275389	Diagnostic workup		TREATS	HP:0100754	Mania	MONDO:0010200				1
33275389	Diagnostic workup		PREVENTS	misdiagnosis		MONDO:0010200				1
33275389	Management of Wilson disease		TREATS	Hepatic abnormalities		MONDO:0010200	with Ceruloplasmin	Ceruloplasmin		1
33275389	Management of Wilson disease		TREATS	Neurological symptoms		Wilson disease		Wilson disease		1
33275389	Management of Wilson disease		TREATS	Psychiatric symptoms		MONDO:0010200				1
32804913	Plasma exchange		TREATS	hemolysis		Fulminant Wilson Disease				1
32804913	Plasma exchange		TREATS	fulminant liver failure		Fulminant Wilson Disease		Plasma exchange		1
32804913	Chelation therapy		TREATS	symptoms		Fulminant Wilson Disease	with D-penicillamine	CHEBI:7959		1
32060651	Treatment		TREATS	neurological symptoms		MONDO:0010200		CHEBI:34936		1
32060651	Treatment		TREATS	neurological symptoms		MONDO:0010200		DMPS and DMSA		1
32060651	Susceptibility-weighted imaging (SWI) examination		DETECTS	abnormal CP values in the pallidum and substantia nigra		MONDO:0010200				1
32060651	Liver function tests		MONITOR	Wilson disease						1
32060651	Treatment		REDUCES	HP:0010836	Abnormal copper levels	MONDO:0010200		CHEBI:34936		1
32060651	Treatment		REDUCES	abnormal copper levels		Wilson disease		DMPS and DMSA	abnormal copper levels	1
31277686	Lifelong pharmacotherapy		TREATS	Hepatic manifestations		MONDO:0010200	Lifelong	pharmacotherapy		1
31277686	Lifelong pharmacotherapy		TREATS	Neurological manifestations		MONDO:0010200		pharmacotherapy		1
31277686	Lifelong pharmacotherapy		TREATS	Psychiatric manifestations		MONDO:0010200				1
31277686	Treatment persistence monitoring		PREVENTS	negative impact on education level and work ability		MONDO:0010200				1
29274796	multidisciplinary closer follow-up		TREATS	non-compliance		MONDO:0010200				1
29274796	treatment		TREATS	non-compliance		MONDO:0010200				1
29274796	questionnaire evaluation		TREATS	non-compliance		Wilson's disease				1
29274796	self-questionnaire collection		TREATS	non-compliance		MONDO:0010200				1
29274796	analysis		TREATS	non-compliance		Wilson's disease		analogic scales		1
29274796	Beck Depression Inventory		TREATS	depressive symptoms		MONDO:0010200				1
29274796	phone call interview		TREATS	non-compliance		MONDO:0010200				1
29274796	treatment		PREVENTS	neurological disorders		MONDO:0010200				1
33275388	Diagnostic workup		TREATS	hepatic symptoms		MONDO:0010200				1
33275388	Diagnostic workup		TREATS	neurological symptoms		Wilson Disease				1
33275388	Diagnostic workup		TREATS	psychiatric symptoms		MONDO:0010200				1
33275388	Diagnostic workup		TREATS	new onset of mania		MONDO:0010200	with	Ceruloplasmin		1
33275388	Magnetic resonance imaging		PREVENTS	misdiagnosis		MONDO:0010200				1
33275388	Ophthalmological and hepatic abnormalities evaluation		TREATS	hepatic symptoms		MONDO:0010200				1
33275388	Copper studies		TREATS	hepatic symptoms		MONDO:0010200				1
33275388	studies		TREATS	neurological symptoms		MONDO:0010200		CHEBI:28694		1
33275388	Copper studies		TREATS	psychiatric symptoms		MONDO:0010200				1
30426382	molecular genetic diagnosis		PREVENTS	copper accumulation		MONDO:0010200		ARMS-PCR		1
30426382	treatment		TREATS	copper accumulation		MONDO:0010200				1
30426382	screening for mutations by T-ARMS-PCR assay		PREVENTS	neurological and psychiatric manifestations		MONDO:0010200		ATP7B	severe	1
30426382	evidence based genetic counseling		PREVENTS	severe neurological and psychiatric manifestations		MONDO:0010200				1
31992405	systematic review and meta-analysis		TREATS	HP:0100785	insomnia	MONDO:0010200				1
31992405	systematic review and meta-analysis		TREATS	rapid eye movement (REM) sleep behavior disorder (RBD)		MONDO:0010200				1
31992405	systematic review and meta-analysis		TREATS	HP:0001262	excessive daytime sleepiness (EDS)	MONDO:0010200				1
31992405	systematic review and meta-analysis		TREATS	HP:0010535	sleep-disordered breathing (SDB)	MONDO:0010200				1
31992405	systematic review and meta-analysis		TREATS	HP:0012452	restless legs syndrome (RLS)	MONDO:0010200				1
31992405	systematic review and meta-analysis		TREATS	periodic limb movement in sleep (PLM)		MONDO:0010200				1
31992405	systematic review and meta-analysis		TREATS	HP:0100580	cataplexy-like episodes (CLEs)	MONDO:0010200				1
31992405	systematic review and meta-analysis		TREATS	HP:0025233	sleep paralysis	MONDO:0010200				1
31992405	polysomnographic studies		OBSERVES	prolonged sleep onset latency		Wilson disease				1
31992405	polysomnographic studies		OBSERVES	REM sleep onset latency		MONDO:0010200				1
31992405	polysomnographic studies		OBSERVES	reduced total sleep time		Wilson disease		polysomnographic studies		1
31992405	polysomnographic studies		OBSERVES	reduced sleep efficiency		MONDO:0010200				1
31992405	polysomnographic studies		OBSERVES	higher percentage of stage N1 sleep		MONDO:0010200				1
31992405	polysomnographic studies		OBSERVES	lower percentage of stage N2 sleep		MONDO:0010200				1
33443665	neurological symptoms evaluation		TREATS	neurological symptom scores		MONDO:0010200				1
33443665	liver function test		TREATS	metal deposition		MONDO:0010200				1
33443665	metal metabolism test		TREATS	metal deposition		MONDO:0010200				1
33443665	susceptibility-weighted imaging (SWI)		TREATS	metal deposition		MONDO:0010200				1
33443665	diffusion tensor imaging (DTI)		TREATS	fiber damage		MONDO:0010200				1
33443665	magnetic resonance spectroscopy (MRS) examination		TREATS	neuronal necrosis		MONDO:0010200				1
29340742	Use of chelating agents		TREATS	hepatic manifestations		MONDO:0010200		CHEBI:38161		1
29340742	Use of chelating agents		TREATS	neurological manifestations		MONDO:0010200		CHEBI:38161		1
29340742	Use of chelating agents		TREATS	psychiatric manifestations		MONDO:0010200		CHEBI:38161		1
29340742	administration		TREATS	hepatic manifestations		MONDO:0010200		Zinc salts		1
29340742	administration		TREATS	neurological manifestations		MONDO:0010200		Zinc salts		1
29340742	administration		TREATS	psychiatric manifestations		MONDO:0010200		Zinc salts		1
28433106	Optimization of treatment regimens		PREVENTS	HP:0001392	Hepatic disease	MONDO:0010200				1
28433106	Chelation		TREATS	neurologic symptoms		MONDO:0010200		CHEBI:30703		1
28433106	Use of nonchelating drugs		PREVENTS	symptoms		MONDO:0010200		nonchelating drugs		1
28433106	MAXO:0000016	Cell therapy	TREATS	HP:0001392	Hepatic disease	MONDO:0010200	research			1
28433106	MAXO:0001001	Gene therapy	TREATS	HP:0001392	Hepatic disease	MONDO:0010200		Gene therapy		1
31570646	Slow periodic myoclonus		IN	Wilson disease						1
30618165	curative liver transplantation		PREVENTS	HP:0001695	cardiac arrest	MONDO:0010200				1
30618165	mass spectrometry		TREATS	myocardial copper and iron accumulation		MONDO:0010200				1
30618165	cardiovascular magnetic resonance		TREATS	HP:0001685	myocardial fibrosis	MONDO:0010200				1
30618165	endomyocardial biopsy		TREATS	HP:0001685	myocardial fibrosis	MONDO:0010200				1
32662046	Assessment		TREATS	dystonia		Wilson Disease		Burke-Fahn-Marsden score		1
32662046	Measurement of serum glutamate, cytokines, oxidative stress markers		PREVENTS	worsening of symptoms		MONDO:0010200	with Malondialdehyde (MDA), Glutamate, Cytokines (IL-6, IL-8, IL-10, TNFalpha), Glutathione, Total antioxidant capacity (TAC)	Glutamate, Cytokines, oxidative stress markers		1
38385422	dose was reduced		TREATS	Cholestatic liver injury		Tacrolimus-Induced Toxicity		CHEBI:61049		1
38385422	Tacrolimus dose was reduced		TREATS	Deranged liver function tests		Tacrolimus-Induced Toxicity		CHEBI:61049		1
38385422	chelating therapy		TREATS	Wilson disease				CHEBI:50868		1
38385422	Liver biopsy		DIAGNOSES	Hepatocellular necrosis		Tacrolimus-Induced Toxicity		Tacrolimus		1
38385422	MAXO:0000376	Liver biopsy	DIAGNOSES	Centrilobular cholestasis		Tacrolimus-Induced Toxicity				1
38385422	Tacrolimus		TREATS	Acute rejection		Liver Transplant	with Tacrolimus	CHEBI:61049		1
32618564	investigation of hemolytic anemia		TREATS	HP:0001878	hemolytic anemia	MONDO:0010200				1
32618564	investigation of hepatic insufficiency		TREATS	HP:0001399	Liver failure	MONDO:0010200				1
32618564	investigation of hypophosphatemia		TREATS	HP:0002148	hypophosphatemia	MONDO:0010200				1
34091542	Diagnosis		TREATS	hepatic manifestations		MONDO:0010200				1
34091542	Diagnosis		TREATS	neurological manifestations		MONDO:0010200				1
34091542	MAXO:0000127	Genetic testing	TREATS	hepatic manifestations		MONDO:0010200				1
34091542	MAXO:0000127	Genetic testing	TREATS	neurological manifestations		MONDO:0010200				1
34091542	Treatment		TREATS	hepatic manifestations		MONDO:0010200		CHEBI:137245		1
34091542	Treatment		TREATS	hepatic manifestations		MONDO:0010200		zinc salts		1
34091542	Treatment		TREATS	hepatic manifestations		MONDO:0010200		CHEBI:39501		1
34091542	MAXO:0001175	liver transplantation	TREATS	hepatic manifestations		MONDO:0010200				1
34091542	MAXO:0001175	liver transplantation	TREATS	neurological manifestations		MONDO:0010200				1
32008504	Liver transplant		TREATS	neurologic symptoms		MONDO:0010200				1
32008504	Increasing urinary copper excretion		TREATS	copper accumulation in various organs		Wilson disease				1
32008504	Evaluation by neurologist and radiologist		TREATS	neurologic symptoms		MONDO:0010200				1
32008504	Cranial magnetic resonance imaging		TREATS	neurologic symptoms		MONDO:0010200				1
32008504	Immunosuppressive therapy		PREVENTS	neurologic symptoms		MONDO:0010200				1
31345362	Analysis of serum levels		TREATS	Hepatic and extrahepatic copper deposition		MONDO:0010200	with	CHEBI:18248		1
31345362	Analysis of serum levels		TREATS	Hepatic and extrahepatic copper deposition		MONDO:0010200	with Zinc (Zn)	CHEBI:27363		1
31345362	Analysis of serum levels		TREATS	Hepatic and extrahepatic copper deposition		MONDO:0010200	with Ferritin (SFr)	CHEBI:82594		1
31345362	Analysis of serum levels		TREATS	Hepatic and extrahepatic copper deposition		MONDO:0010200	with Serum copper (SCu)			1
31345362	Analysis of serum levels		TREATS	Hepatic and extrahepatic copper deposition		MONDO:0010200	with Serum zinc (SZn)	Serum zinc (SZn)		1
34627751	Diet modification		PREVENTS	HP:0001397	Liver steatosis	MONDO:0010200				1
34627751	Diet modification		TREATS	Inflammation		MONDO:0010200				1
34627751	Serum and liver metabolite analysis		TREATS	HP:0001397	Liver steatosis	MONDO:0010200				1
34627751	Body fat content analysis		TREATS	HP:0001397	Liver steatosis	MONDO:0010200				1
34627751	Liver histology examination		TREATS	HP:0001397	Liver steatosis	MONDO:0010200				1
34627751	Hepatic proteome analysis		TREATS	HP:0001397	Liver steatosis	MONDO:0010200				1
34627751	Copper content analysis		TREATS	Copper accumulation		Wilson Disease		Copper content analysis	Copper accumulation	1
32520831	MAXO:0001175	liver transplantation	TREATS	HP:0006554	acute liver failure	MONDO:0010200				1
32520831	spontaneous recovery		TREATS	acute liver failure		Wilson Disease				1
32520831	MAXO:0001175	liver transplantation	TREATS	HP:0003256	coagulopathy	MONDO:0010200				1
32520831	MAXO:0001175	liver transplantation	TREATS	HP:0002480	hepatic encephalopathy	MONDO:0010200				1
30357869	High-Volume Plasma Exchange		TREATS	Acute Liver Failure		Wilson Disease	High-Volume	Plasma Exchange		1
30357869	Penicillamine		TREATS	HP:0006554	Acute Liver Failure	MONDO:0010200	with Penicillamine	CHEBI:50868		1
29321352	MAXO:0000127	Genetic analysis	TREATS	Wilson disease						1
29321352	Sanger sequencing		TREATS	Wilson disease						1
29321352	mutation screening		TREATS	Wilson disease						1
29321352	direct DNA sequencing		TREATS	Wilson disease						1
38175989	Neuroimaging		TREATS	abnormal body movements		MONDO:0010200				1
38175989	Neuroimaging		TREATS	HP:0002063	rigidity	MONDO:0010200				1
38175989	Neuroimaging		TREATS	HP:0001332	Dystonia	MONDO:0010200				1
38175989	Ophthalmologic examination		TREATS	bilateral Kayser-Fleischer rings		MONDO:0010200				1
38175989	"Serum ""free"" copper levels measurement"		TREATS	abnormal body movements		MONDO:0010200	with copper	CHEBI:28694		1
38175989	24-hour urine copper levels measurement		TREATS	abnormal body movements		MONDO:0010200	with copper	CHEBI:28694		1
38175989	Serum ceruloplasmin levels measurement		TREATS	abnormal body movements		MONDO:0010200	with ceruloplasmin	ceruloplasmin		1
34087921	Blind liver biopsy		TREATS	Chronic active hepatitis B		Liver disease				1
34087921	Blind liver biopsy		TREATS	Neonatal cholestasis		MONDO:0005154				1
34087921	Blind liver biopsy		TREATS	Autoimmune hepatitis		MONDO:0005154				1
34087921	Blind liver biopsy		TREATS	Wilson disease		MONDO:0005154				1
34087921	Blind liver biopsy		TREATS	Isolated elevation of the liver enzymes		MONDO:0005154				1
34087921	Blind liver biopsy		TREATS	Chronic active hepatitis C		MONDO:0005154				1
34087921	Blind liver biopsy		TREATS	Metabolic disease		MONDO:0005154				1
34087921	Blind liver biopsy		TREATS	Malignancies		MONDO:0005154				1
33541028	treatment		TREATS	Wilson Disease				CHEBI:50868		1
33541028	treatment		TREATS	Wilson Disease				sodium dimercaptopropane sulfonate		1
33541028	treatment		TREATS	Wilson Disease				ammonium tetrathiomolybdate		1
33541028	treatment		TREATS	Wilson Disease				CHEBI:27363		1
33541028	MAXO:0001175	liver transplantation	TREATS	Wilson Disease						1
33541028	MAXO:0001001	gene therapy	TREATS	Wilson Disease						1
30879594	Percutaneous transhepatic biliary drainage		TREATS	reiterated cholangitis		MONDO:0004789				1
30879594	Increasing the size of the drainage tube		TREATS	bile leakage		MONDO:0004789				1
30879594	Dilating the anastomotic area with a balloon catheter		TREATS	stenosis of hepaticojejunostomy anastomosis		MONDO:0004789				1
30879594	Stone crushing		TREATS	multiple stones in the intrahepatic bile ducts		MONDO:0004789		electronic hydraulic lithotripsy		1
30879594	Lithotomy through cholangioscopy		TREATS	multiple stones in the intrahepatic bile ducts		Cholangitis		cholangioscopy	multiple stones	1
30879594	Lithotomy		TREATS	stones in the intrahepatic bile ducts		MONDO:0004789	through endoscopic retrograde cholangiography	endoscopic retrograde cholangiography	multiple stones	1
30879594	Rendezvous technique		TREATS	intrahepatic bile ducts		Cholangitis		double balloon endoscope	multiple stones	1
29692402	MAXO:0000376	liver biopsy	TREATS	HP:0000952	jaundice	MONDO:0007329				1
29692402	MAXO:0000376	liver biopsy	TREATS	HP:0001945	fever	MONDO:0007329				1
29692402	MAXO:0000376	liver biopsy	TREATS	persistently increasing bilirubin		MONDO:0007329				1
29692402	MAXO:0000376	liver biopsy	TREATS	HP:0002908	direct hyperbilirubinemia	MONDO:0007329				1
29692402	liver biopsy		TREATS	elevated transaminases		Indian childhood cirrhosis				1
29692402	MAXO:0000376	liver biopsy	TREATS	HP:0001903	anemia	MONDO:0007329				1
29692402	liver biopsy		TREATS	schistocytes in blood		Indian childhood cirrhosis	NA	NA	NA	1
29692402	MAXO:0000376	liver biopsy	TREATS	positive direct coombs test		MONDO:0007329				1
29692402	MAXO:0000376	liver biopsy	TREATS	deranged prothrombin time		MONDO:0007329				1
29692402	liver biopsy		TREATS	chronic liver disease		Indian childhood cirrhosis				1
29692402	MAXO:0000376	liver biopsy	TREATS	HP:0001409	portal hypertension	MONDO:0007329				1
29692402	MAXO:0000376	liver biopsy	TREATS	HP:0001541	Ascites	MONDO:0007329				1
36071243	MAXO:0009004	Exome sequencing	TREATS	moderate to severe disease		MONDO:0010200		Exome sequencing		1
36071243	MAXO:0009004	Exome sequencing	TREATS	moderate to severe disease		MONDO:0100288				1
36071243	MAXO:0009004	Exome sequencing	TREATS	moderate to severe disease		MONDO:0012669				1
36071243	Exome sequencing		TREATS	moderate to severe disease		Muenke syndrome				1
30686905	Monitoring for associated complications		TREATS	HP:0001744	Splenomegaly	Wilson disease-associated cirrhosis				1
30686905	Monitoring for associated complications		PREVENTS	progression from Child-Pugh grade A to B		Wilson disease-associated cirrhosis				1
30686905	Monitoring for associated complications		PREVENTS	HP:0001541	Ascites	Wilson disease-associated cirrhosis				1
34144249	Propensity-score matched analysis		PREVENTS	inpatient mortality		Wilson's disease				1
34144249	acute respiratory failure		TREATS	HP:0002878	acute respiratory failure	MONDO:0010200				1
34144249	acute renal failure		TREATS	acute renal failure		Wilson's disease				1
34144249	decompensated liver disease		TREATS	decompensated liver disease		Wilson's disease				1
34144249	liver failure		TREATS	HP:0001399	Hepatic failure	MONDO:0010200				1
29527989	Liver transplant		TREATS	dysfunction due to copper accumulation		MONDO:0010200				1
29527989	Seizure control medication		TREATS	HP:0001250	Epileptic seizures	MONDO:0010200	with Levetiracetam	CHEBI:6437		1
28861905	medications		TREATS	movement disorders		Rare movement disorders		Specific medications	Rare	1
28861905	Dietary changes		PREVENTS	movement disorders		Rare movement disorders		Dietary changes		1
28861905	Avoidance or management of triggers		PREVENTS	HP:0100022	Movement disorders	MONDO:0015143				1
28861905	Enzyme replacement therapy		TREATS	movement disorders		Rare movement disorders		Enzyme replacement therapy		1
28516971	Saliva testing		TREATS	diagnosis		Various diseases				1
28516971	Proteomic analysis		TREATS	diagnosis		Various diseases				1
37936530	Living donor liver transplant		TREATS	chronic liver disease		Pediatric liver diseases				1
37936530	Living donor liver transplant (LDLT)		TREATS	HP:0006554	acute liver failure	Pediatric liver diseases				1
37936530	Nutritional rehabilitation		PREVENTS	chronic liver disease		Pediatric liver diseases				1
37936530	Anticipation and management of post-operative complications		PREVENTS	HP:0002204	Pulmonary embolism	Pediatric liver diseases				1
37936530	Anticipation and management of post-operative complications		PREVENTS	HP:0100806	Sepsis	Pediatric liver diseases				1
37936530	Anticipation and management of post-operative complications		PREVENTS	surgical complications		Pediatric liver diseases				1
37936530	Anticipation and management of post-operative complications		PREVENTS	HP:0001919	acute renal failure	Pediatric liver diseases				1
29579829	liver transplant		TREATS	high mortality		MONDO:0019542				1
29579829	liver transplant		TREATS	encephalopathy grade III to IV		MONDO:0019542				1
30368998	MAXO:0001298	therapy	TREATS	severe acute liver failure		MONDO:0010200		CHEBI:27363		1
30368998	MAXO:0001298	therapy	TREATS	severe acute liver failure		MONDO:0010200		CHEBI:38161		1
30368998	Plasma exchange		TREATS	severe acute liver failure		Wilson disease		Plasma exchange		1
30368998	Continuous hemodiafiltration		TREATS	severe acute liver failure		MONDO:0010200				1
30368998	Liver transplantation		TREATS	severe acute liver failure		Wilson disease	n/a	n/a	n/a	1
30368998	Liver transplantation		TREATS	bleeding		Wilson disease		Liver transplantation	esophageal varix	1
32067425	utilization of a multiplexed biomarker peptide quantification method		PREVENTS	reduction in circulating B lymphocytes		X-linked agammaglobulinemia		multiplexed biomarker peptide quantification method		1
32067425	utilization		PREVENTS	decrease in serum immunoglobulins		X-linked agammaglobulinemia		multiplexed biomarker peptide quantification method		1
32067425	newborn screening (NBS)		PREVENTS	reduction in circulating B lymphocytes		MONDO:0010421				1
32067425	newborn screening (NBS)		PREVENTS	decrease in serum immunoglobulins		MONDO:0010421				1
28715695	Immunohistochemical expression analysis		TREATS	HP:0001402	Hepatocellular carcinoma (HCC)					1
28715695	Immunoblot analysis		TREATS	HP:0001402	Hepatocellular carcinoma (HCC)	MONDO:0007256				1
32276787	determination of reference intervals for spot urine		PREVENTS	presymptomatic stage		Wilson disease		copper excretion indexes		1
32276787	receiver operator curve (ROC) analysis		TREATS	presymptomatic stage of Wilson disease		MONDO:0010200	with copper	CHEBI:28694		1
32276787	application of a bivariate screening strategy using spot urine copper concentration and urine osmolality		PREVENTS	presymptomatic stage of Wilson disease		MONDO:0010200				1
30665472	Longitudinal measurement of motor threshold		TREATS	High resting motor threshold (RMT)		MONDO:0010200				1
30665472	Chelation therapy		PREVENTS	Poor global assessment scores in Wilson Disease (GAS-WD)		MONDO:0010200				1
30665472	Chelation therapy		DOES NOT TREAT	Impaired central motor conduction time (CMCT)		Wilson's Disease				1
28975833	Treating		PREVENTS	increased risk of developing HCC		MONDO:0007256		underlying liver disease		1
28975833	Reducing the progression to cirrhosis		PREVENTS	increased incidence of HCC		MONDO:0007256	NA	CHEBI:26708	NA	1
33369596	24-hour urinary copper excretion (UCE) test		ASSESSES	efficacy of Chelation therapy		MONDO:0010200		Chelation therapy		1
33369596	Penicillamine challenge test INITIATES reduction of nonceruloplasmin-bound copper concentration		TREATS	Wilson Disease				CHEBI:50868		1
33369596	Chelation therapy		TREATS	Wilson Disease			with Penicillamine	CHEBI:50868	urinary copper excretion	1
33369596	Chelation therapy		PREVENTS	Progressive liver disease		MONDO:0010200		Chelation therapy		1
33369596	Chelation therapy		PREVENTS	signs of copper deficiency		MONDO:0010200		Chelation therapy		1
31568969	use of melatonin		TREATS	excessive copper accumulation in cells		MONDO:0010200		CHEBI:16796		1
31568969	use of melatonin		TREATS	subcellular lesions		MONDO:0010200		CHEBI:16796		1
31568969	use of melatonin		TREATS	fibrosis/cirrhosis		MONDO:0010200	with Melatonin	CHEBI:16796	in the liver	1
34320232	Designing Clinical Trials		PREVENTS	pathological accumulation of copper in the liver and brain		MONDO:0010200				1
34320232	Adoption of initial treatments		TREATS	pathological accumulation of copper in the liver and brain		MONDO:0010200				1
34320232	development of treatment modalities		TREATS	pathological accumulation of copper in the liver and brain		MONDO:0010200				1
34320232	recruitment of patients		TREATS	pathological accumulation of copper in the liver and brain		MONDO:0010200				1
35470480	Genetic testing		PREVENTS	significant disability		Wilson disease	null	null	null	1
35470480	MAXO:0000127	Genetic testing	PREVENTS	death		MONDO:0010200				1
30541745	FDA approval		TREATS	HP:0004808	Acute Myeloid Leukemia	MONDO:0018874	with Daunorubicin and Cytarabine	Vyxeos	High-Risk	1
30541745	Randomized, multicenter, open-label, active-controlled trial		PREVENTS	unknown symptoms		MONDO:0018874				1
30541745	Warning against interchanging formulations		PREVENTS	medication error		MONDO:0018874				1
36571168	MAXO:0001077	Splenectomy	TREATS	HP:0001971	Hypersplenism	MONDO:0010200				1
36571168	Establishing a personalized nomogram		PREVENTS	Portal Vein System Thrombosis (PVST)		Wilson disease		personalized nomogram		1
36571168	Least absolute shrinkage and selection operator regression analysis		PREVENTS	Portal Vein System Thrombosis		MONDO:0010200		LASSO regression analysis		1
36571168	Multivariate logistic regression analysis		PREVENTS	Portal Vein System Thrombosis (PVST)		MONDO:0010200				1
36571168	Calculation of the concordance (C)-index		PREVENTS	Portal Vein System Thrombosis (PVST)		MONDO:0010200				1
36571168	Drawing the receiver operating characteristic (ROC) curve		PREVENTS	Portal Vein System Thrombosis (PVST)		MONDO:0010200				1
36571168	Drawing the model calibration curve		PREVENTS	Portal Vein System Thrombosis (PVST)		MONDO:0010200				1
36571168	Drawing the clinical decision analysis (DCA) curve		PREVENTS	Portal Vein System Thrombosis (PVST)		MONDO:0010200				1
36571168	Internal validation		PREVENTS	Portal Vein System Thrombosis (PVST)		Wilson disease		model		1
33640437	Direct measurement		TREATS	Ambiguous genetic results		MONDO:0010200		ATP7B peptides		1
33640437	Direct measurement		TREATS	ATP7B deficiency		Wilson Disease		ATP7B peptides	ATP7B deficiency	1
33640437	Immunoaffinity enrichment mass spectrometry		TREATS	ATP7B deficiency		MONDO:0010200	with Ceruloplasmin	Ceruloplasmin		1
34999690	serum free copper testing		TREATS	liver disease		Wilson disease		serum free copper testing		1
34999690	24 hours urine copper estimation		TREATS	HP:0001392	liver disease	MONDO:0010200		copper estimation	liver disease	1
34999690	hepatic copper estimation		TREATS	HP:0001392	liver disease	MONDO:0010200		hepatic copper estimation		1
34999690	genetic mutation testing		TREATS	HP:0001392	liver disease	MONDO:0010200				1
34999690	Leipzig score diagnosis		TREATS	HP:0001392	liver disease	MONDO:0010200		Leipzig score diagnosis		1
34999690	slit lamp eye examination		TREATS	KF ring		Wilson disease		slit lamp		1
34999690	serum ceruloplasmin testing		TREATS	HP:0001392	liver disease	MONDO:0010200				1
34999690	serum free copper testing		TREATS	progressive neurological disorder		Wilson disease		serum free copper testing		1
34999690	24 hours urine copper estimation		TREATS	progressive neurological disorder		MONDO:0010200				1
34999690	hepatic copper estimation		TREATS	progressive neurological disorder		MONDO:0010200				1
34999690	genetic mutation testing		TREATS	progressive neurological disorder		MONDO:0010200				1
34999690	Leipzig score diagnosis		TREATS	progressive neurological disorder		Wilson disease		Leipzig score diagnosis		1
34999690	slit lamp eye examination		TREATS	progressive neurological disorder		MONDO:0010200				1
34999690	serum ceruloplasmin testing		TREATS	progressive neurological disorder		MONDO:0010200		ceruloplasmin		1
34999690	serum free copper testing		TREATS	psychiatric illness		Wilson disease		serum free copper testing		1
34999690	24 hours urine copper estimation		TREATS	psychiatric illness		Wilson disease		copper		1
34999690	hepatic copper estimation		TREATS	psychiatric illness		MONDO:0010200				1
34999690	genetic mutation testing		TREATS	psychiatric illness		Wilson disease		genetic mutation testing		1
34999690	diagnosis		TREATS	psychiatric illness		Wilson disease		Leipzig score		1
34999690	slit lamp eye examination for KF ring		TREATS	psychiatric illness		MONDO:0010200				1
34999690	serum ceruloplasmin testing		TREATS	psychiatric illness		MONDO:0010200				1
33881171	MAXO:0000969	optical coherence tomography (OCT)	ASSESSES	morphological changes of the retina		MONDO:0010200				1
33881171	chelation therapy		TREATS	copper accumulation and deposition in different organs		MONDO:0010200		chelation		1
33881171	MAXO:0001298	therapy	TREATS	copper accumulation and deposition in different organs		MONDO:0010200		zinc salts		1
31511488	treatment		TREATS	HP:0001410	Hepatic dysfunction	MONDO:0010200		CHEBI:7959		1
31511488	treatment		TREATS	liver dysfunction		Wilson Disease		Zinc acetate		1
31511488	MAXO:0000376	liver biopsy	TREATS	HP:0001410	Hepatic dysfunction	MONDO:0010200				1
31511488	Laboratory tests		PREVENT	mismanagement		MONDO:0010200				1
31511488	Measurement of hepatic copper content		TREATS	HP:0001410	Hepatic dysfunction	MONDO:0010200				1
31169307	Orthotopic liver transplantation		TREATS	fulminant WD		Wilson disease	null	null	null	1
31169307	Chelation therapy		TREATS	asymptomatic phase		MONDO:0010200		Chelation		1
33244627	neuropsychiatric assessment		TREATS	hepatic or neuropsychiatric symptoms		MONDO:0010200				1
33244627	Unified WD Rating Scale neurological exam		PREVENTS	undiagnosed neurological involvement		MONDO:0010200				1
33244627	3 Tesla anatomical and resting-state functional MRI		TREATS	undiagnosed structural and functional brain changes		Wilson disease		3 Tesla anatomical and resting-state functional MRI		1
33244627	Diffusion tensor imaging (DTI)		TREATS	diminished white matter integrity		MONDO:0010200				1
33244627	susceptibility-weighted imaging (SWI)		TREATS	subcortical hypointense lesions		Wilson disease		susceptibility-weighted imaging	subcortical hypointense lesions	1
33244627	volumetric analysis		TREATS	striatal and thalamic atrophy		Wilson disease				1
33244627	functional connectivity analysis		TREATS	changes in functional connectivity		MONDO:0010200				1
33244627	longitudinal brain MRI scans		PREVENTS	progression		MONDO:0010200	without monitoring			1
34627038	Immunohistochemistry		PREVENTS	unclear visualization		MONDO:0005154				1
34627038	Paraffin embedding after formalin fixation		TREATS	unclear morphological structure identification		MONDO:0005154				1
34627038	Cryopreservation		TREATS	unclear morphological structure identification		MONDO:0005154				1
34627038	Antigen retrieval		TREATS	unclear morphological structure identification		MONDO:0005154				1
34627038	Chromogenic detection		PREVENTS	unclear visualization		MONDO:0005154		Chromogenic detection		1
34627038	Fluorescent detection		PREVENTS	unclear visualization		Liver diseases		Fluorescent detection		1
34627038	Quantitative color intensity measurement		PREVENTS	inaccurate assessment		MONDO:0005154				1
29085216	Full physical exam		TREATS	HP:0001410	Hepatic dysfunction	MONDO:0010200				1
29085216	Ophthalmologic slit-lamp examination		TREATS	HP:0001410	Hepatic dysfunction	MONDO:0010200				1
29085216	Ultrasound imaging of the liver		TREATS	HP:0001410	Hepatic dysfunction	MONDO:0010200				1
29085216	Measurement of serum ceruloplasmin		TREATS	hepatic dysfunction		Wilson's disease		ceruloplasmin		1
29085216	Measurement		TREATS	hepatic dysfunction		Wilson's disease		24-h urinary-Cu levels		1
29085216	Genetic screening		TREATS	HP:0001410	Hepatic dysfunction	MONDO:0010200	using	PCR		1
29085216	Sequencing		TREATS	HP:0001410	Hepatic dysfunction	MONDO:0010200				1
28619500	Endoscopic cyst fenestration		TREATS	intractable seizure		MONDO:0010200				1
28619500	administration of antiepileptics		FAILS TO TREAT	intractable seizure		MONDO:0010200		CHEBI:35623		1
34608110	Oral chelation therapy		TREATS	symptomatic disease		MONDO:0010200	Oral	chelation therapy		1
34608110	MAXO:0001175	liver transplantation	TREATS	symptomatic disease		MONDO:0010200				1
34608110	Treatment with penicillamine		TREATS	symptomatic disease		MONDO:0010200	with Penicillamine	CHEBI:50868		1
34608110	Oral chelation therapy		PREVENTS	liver transplantation		MONDO:0010200	Oral	chelation therapy		1
29504323	recording of resting ECG		TREATS	HP:0005135	T wave abnormality	MONDO:0010200				1
29504323	cardiac magnetic resonance imaging (MRI)		TREATS	cardiomyopathy		MONDO:0010200				1
29504323	MAXO:0010203	echocardiography	TREATS	ECG abnormalities		MONDO:0010200				1
31933160	Differential diagnosis		TREATS	Neurological manifestations		MONDO:0018982				1
31933160	Screening		TREATS	Neurological manifestations		MONDO:0018982				1
30601285	In vivo confocal microscopy (IVCM) imaging		TREATS	abnormal patterns in the peripheral Descemet membrane		Wilson Disease		In vivo confocal microscopy (IVCM) imaging	abnormal patterns	1
30601285	in vivo confocal microscopy (IVCM) imaging		TREATS	patchy patterns		MONDO:0010200				1
30601285	in vivo confocal microscopy (IVCM) imaging		TREATS	stripy patterns		MONDO:0010200		confocal microscopy		1
30601285	in vivo confocal microscopy (IVCM) imaging		TREATS	spotty patterns		MONDO:0010200				1
29417175	standard oral dosing		TREATS	Wilson disease			with trientine	CHEBI:39501		1
29417175	plasma trientine concentration determination (with LC-MS/MS)		TREATS	Wilson disease				CHEBI:39501		1
33368534	high volume plasma exchange		TREATS	acute liver failure		Wilson disease presenting as acute liver failure	high volume			1
33368534	standard medical therapy		TREATS	acute liver failure		Wilson disease		SMT		1
34405819	Evaluation		PREVENTS	HP:0001399	Hepatic failure	MONDO:0016264		diagnostic criteria		1
34405819	Evaluation of diagnostic criteria		PREVENTS	HP:0001394	Cirrhosis	MONDO:0016264	N/A	N/A	N/A	1
34405819	Use of International Autoimmune Hepatitis Group (IAIHG) simplified scoring system		TREATS	HP:0001399	Hepatic failure	MONDO:0016264		International Autoimmune Hepatitis Group (IAIHG) simplified scoring system		1
34405819	Use of new scoring system		TREATS	cirrhosis		MONDO:0016264		new scoring system		1
34405819	IgG levels measurement		TREATS	HP:0001399	Hepatic failure	MONDO:0016264	with IgG	IgG		1
34405819	Hepatic histology examination		TREATS	HP:0001394	Cirrhosis	MONDO:0016264				1
28433100	Diagnosis		TREATS	HP:0001392	Hepatic disease	MONDO:0010200				1
28433100	Neurologic examination		TREATS	Neuropsychiatric disturbances		MONDO:0010200				1
28433100	Neuroimaging		TREATS	Neuropsychiatric disturbances		Wilson disease				1
28433100	Electrophysiologic methods		TREATS	Neuropsychiatric disturbances		MONDO:0010200				1
28433100	Clinical signs scoring		TREATS	Liver disease		Wilson disease			Liver disease	1
28433100	Clinical signs scoring		TREATS	HP:0200032	Kayser-Fleischer rings	MONDO:0010200				1
28433100	Laboratory features scoring		TREATS	HP:0001392	Hepatic disease	MONDO:0010200	with Copper	CHEBI:28694		1
28433100	Laboratory features scoring		TREATS	HP:0001392	Hepatic disease	MONDO:0010200	with Ceruloplasmin	Ceruloplasmin		1
28433100	Leipzig score calculation		TREATS	Kayser-Fleischer rings		Wilson disease		Leipzig score calculation	Kayser-Fleischer rings	1
28433100	Mutation analysis		PREVENTS	HP:0001392	Hepatic disease	MONDO:0010200				1
31878905	pre-pregnancy copper chelation therapy		TREATS	worsening of Wilson disease symptoms		MONDO:0010200	pre-pregnancy	copper chelation therapy		1
31878905	stopping anti-copper therapy during pregnancy		PREVENTS	worsening of Wilson disease symptoms		MONDO:0010200		anti-copper therapy		1
31878905	pre-pregnancy copper chelation therapy		TREATS	lower limb edema		MONDO:0010200	pre-pregnancy	copper chelation therapy	anti-copper therapy	1
31878905	pre-pregnancy copper chelation therapy		PREVENTS	HP:0005268	spontaneous abortions	MONDO:0010200		anti-copper therapy		1
31878905	copper chelation therapy		PREVENTS	lower average infant birth weight		MONDO:0010200	pre-pregnancy	anti-copper therapy		1
32886541	symptomatic management		TREATS	bilateral calf pain		MONDO:0010200				1
32886541	symptomatic management		TREATS	intermittent cramps		MONDO:0010200				1
32886541	MRI of calf muscle		TREATS	diagnosis of muscle involvement		MONDO:0010200				1
32886541	serum alkaline phosphatase testing		TREATS	diagnosis of muscle involvement		Wilson Disease		serum alkaline phosphatase testing		1
32886541	creatinine phosphokinase testing		TREATS	diagnosis of muscle involvement		Wilson Disease		creatinine phosphokinase testing		1
32886541	needle electromyography		TREATS	diagnosis of muscle involvement		MONDO:0010200				1
32886541	muscle toxicity		CAUSES	bilateral calf pain		MONDO:0010200	copper-induced	CHEBI:28694		1
32886541	muscle toxicity		CAUSES	intermittent cramps		MONDO:0010200	copper-induced	CHEBI:28694		1
32291276	MAXO:0001298	therapy	TREATS	HP:0000819	diabetes	MONDO:0010200		CHEBI:7959	severe	1
32291276	prescribed		TREATS	memory issues		MONDO:0010200	capsules	CHEBI:63623		1
32291276	decreased insulin dosage		PREVENTS	increased levels of fasting blood glucose		MONDO:0010200		CHEBI:145810		1
32291276	MAXO:0001298	therapy	PREVENTS	increased levels of fasting blood glucose		MONDO:0010200		CHEBI:7959		1
29449431	liver transplantation		TREATS	acute liver failure		Wilson disease				1
29358698	editing		TREATS	Increased copper content in the liver		MONDO:0010200		CRISPR/Cas9 system combined with single-strand DNA oligonucleotides (ssODNs)		1
29358698	HCG treatment		PREVENTS	Death at approximately three months of age		MONDO:0010200				1
30888628	Liver Transplant		TREATS	mortality		decompensated Wilson Disease				1
30888628	medical management		TREATS	mortality		decompensated Wilson Disease				1
33663358	Liver transplant		TREATS	Acute-on-Chronic Liver Failure		in Children				1
33663358	Patient referral to a transplant center		PREVENTS	complications		Acute-on-Chronic Liver Failure in Children				1
32043565	MAXO:0000127	genetic testing	TREATS	clinical signs		MONDO:0010200				1
32043565	analysis of exons		TREATS	clinical signs		MONDO:0010200				1
32043565	MAXO:0009004	Exome sequencing	TREATS	clinical signs		MONDO:0010200				1
32043565	study of large deletions/duplications by multiplex ligation-dependent probe amplification		TREATS	clinical signs		Wilson's disease		multiplex ligation-dependent probe amplification		1
30635331	MR imaging of the brain		TREATS	abnormalities		Neurologic Wilson Disease				1
30635331	MR imaging of the brain		TREATS	torsion spasm		Neurologic Wilson Disease		MR imaging		1
30635331	MR imaging of the brain		TREATS	HP:0001266	choreoathetosis	Neurologic Wilson Disease				1
30706949	Gene therapy		TREATS	disrupted copper homeostasis		MONDO:0010200		adeno-associated vector (AAV) serotype 8 encoding ATP7B	disrupted copper homeostasis	1
30706949	Generation of an optimized shorter AAV vector		TREATS	disrupted copper homeostasis		MONDO:0010200	optimized shorter	AAV vector		1
30706949	Administration		PREVENTS	liver damage		MONDO:0010200		AAVAnc80-miniATP7B		1
30706949	Administration		TREATS	disrupted copper homeostasis		MONDO:0010200		AAVAnc80-miniATP7B		1
28433103	MAXO:0001175	liver transplantation	TREATS	HP:0100626	End-stage liver diseases	MONDO:0010200				1
28433103	MAXO:0001175	liver transplantation	TREATS	HP:0001409	portal hypertension	MONDO:0010200				1
28433103	MAXO:0001175	liver transplantation	TREATS	HP:0001402	Hepatocellular carcinoma (HCC)	MONDO:0010200				1
28433103	Supportive measures		PREVENTS	complications		MONDO:0010200				1
28433103	hepatocyte transplantation		SUPPLEMENTS	treatment		MONDO:0010200				1
28433103	stem cell transplantation supplements treatment		IN	Wilson disease			Future	stem cell transplantation		1
34866098	MAXO:0001193	upper endoscopy	DETECTS	lustrous white erosions		MONDO:0010200				1
34866098	biopsy		DETECTS	copper deposition		MONDO:0010200				1
34866098	treatment		TREATS	copper deposition		MONDO:0010200	with zinc acetate	CHEBI:62984		1
38317346	Liver transplant		TREATS	HP:0006554	acute liver failure	MONDO:0100192				1
38317346	Liver transplant		TREATS	Decompensated chronic liver disease		MONDO:0100192				1
38317346	Liver transplant		TREATS	acute on chronic liver failure		MONDO:0100192				1
30359967	Plasmapheresis		TREATS	hemolysis		MONDO:0010200				1
30359967	Continuous Plasma Filtration Adsorption (CPFA)		TREATS	severe hemolysis		MONDO:0010200				1
30359967	Chelation therapy		TREATS	severe hemolysis		MONDO:0010200		Chelation therapy		1
30359967	Plasmapheresis		TREATS	impending acute liver failure (ALF)		MONDO:0010200				1
30359967	Continuous Plasma Filtration Adsorption (CPFA)		TREATS	impending acute liver failure (ALF)		MONDO:0010200				1
30359967	Chelation therapy		TREATS	impending acute liver failure		Wilson's Disease		Chelation		1
30359967	MAXO:0001175	liver transplantation	TREATS	Wilson's Disease						1
28719006	Measuring		PREVENTS	chronic liver diseases		Wilson disease		exchangeable serum copper levels	chronic liver diseases	1
28719006	Measuring of relative exchangeable copper		PREVENTS	chronic liver diseases		MONDO:0010200				1
31161407	extensively treated to reduce the body copper		TREATS	marked copper deposition		Idiopathic copper toxicosis (ICT)				1
31161407	liver transplantation		TREATS	severe hepatic injury		Idiopathic copper toxicosis (ICT)				1
29723692	recommended age-specific diagnostic tests		PREVENTS	Indeterminate diagnosis		MONDO:0019542				1
29723692	Electronic medical record admission order set		PREVENTS	Indeterminate diagnosis		MONDO:0019542				1
29723692	MAXO:0001175	liver transplantation	TREATS	HP:0006554	Acute Liver Failure					1
28732478	Comparative assessment of clinical rating scales		PREVENTS	Misdiagnosis		Wilson's disease				1
28732478	Prospective, monocentric, cross-sectional study		PREVENTS	Misdiagnosis		Wilson's disease		Prospective, monocentric, cross-sectional study		1
28732478	Scoring according to the Unified Wilson's Disease Rating Scale		TREATS	Multifaceted neurological symptoms		MONDO:0010200				1
28732478	Scoring		TREATS	Multifaceted neurological symptoms		Wilson's disease		Global Assessment Scale for Wilson's disease	Multifaceted neurological symptoms	1
28732478	Comparative assessing the Unified Wilson's Disease Rating Scale and the Global Assessment Scale for Wilson's disease		TREATS	Multifaceted neurological symptoms		MONDO:0010200				1
28732478	Testing the feasibility of the patient reported part of the UWDRS neurological subscale		TREATS	Multifaceted neurological symptoms		Wilson's disease				1
28732478	Correlation analysis		TREATS	Hepatic symptoms		Wilson's disease		Model for End Stage Liver Disease score		1
28732478	Correlation analysis with the Child-Pugh score		TREATS	Hepatic symptoms		MONDO:0010200				1
28536976	memory and learning assessment		TREATS	memory dysfunction		Copper Toxicity		Y-maze	memory dysfunction	1
28536976	Measuring oxidative stress markers		PREVENTS	excitotoxicity		Copper Toxicity	with glutathione	CHEBI:16856		1
28536976	Immunohistochemistry		TREATS	apoptosis and astrocytic reaction		Copper Toxicity		caspase-3 and GFAP		1
33316133	magnetic resonance imaging		PREVENTS	misdiagnosis		MONDO:0010200				1
33316133	Magnetic resonance imaging		TREATS	Lack of information		MONDO:0010200				1
30861190	treatment		PREVENTS	progression to renal insufficiency		MONDO:0010200	with	CHEBI:7959		1
30861190	serum ceruloplasmin tests		TREATS	Wilson disease						1
30861190	serum creatinine tests		TREATS	Wilson disease						1
30861190	blood urea nitrogen tests		TREATS	Wilson disease						1
30861190	urinalysis		TREATS	Wilson disease						1
30861190	urinary albumin/creatinine ratio tests		TREATS	Wilson disease						1
30861190	urinary calcium/creatinine ratio tests		TREATS	Wilson disease						1
30861190	urinary beta2-microglobulin tests		TREATS	Wilson disease				beta2-microglobulin tests		1
37565896	Prompt anticoagulation		TREATS	acute mesenteric ischemia		Acute mesenteric ischemia	Prompt	anticoagulation		1
37565896	Intravenous fluids		TREATS	acute mesenteric ischemia		Acute mesenteric ischemia		Intravenous fluids		1
37565896	Antibiotic administration		TREATS	acute mesenteric ischemia		Acute mesenteric ischemia				1
37565896	Conservative therapy with close monitoring		TREATS	acute mesenteric ischemia		Acute mesenteric ischemia				1
37565896	Sustained anticoagulant therapy		TREATS	acute mesenteric ischemia		Acute mesenteric ischemia		anticoagulant therapy		1
31653639	repeating a ceruloplasmin level		TREATS	worsening abdominal distension		Wilson disease		ceruloplasmin level		1
31653639	repeating a ceruloplasmin level		TREATS	jaundice		Wilson disease		ceruloplasmin level		1
31653639	repeating a ceruloplasmin level		TREATS	HP:0006554	acute liver failure	MONDO:0010200	with ceruloplasmin	ceruloplasmin		1
31653639	repeating a ceruloplasmin level		TREATS	acute-on-chronic liver failure		MONDO:0010200		ceruloplasmin		1
31653639	repeating a ceruloplasmin level		TREATS	HP:0001919	acute renal failure	MONDO:0010200		ceruloplasmin		1
31653639	repeating a ceruloplasmin level		TREATS	hyperbilirubinaemia		MONDO:0010200	with ceruloplasmin	ceruloplasmin		1
32398357	MAXO:0001175	liver transplantation	TREATS	severe neurologic worsening		MONDO:0010200				1
32398357	active chelation		PREVENTS	severe neurologic worsening		MONDO:0010200	with chelators	CHEBI:38161		1
32398357	use of chelators		TREATS	severe neurologic worsening		MONDO:0010200		CHEBI:38161		1
32398357	use of zinc salts		TREATS	severe neurologic worsening		MONDO:0010200		zinc salts		1
32726213	Pericardiectomy		TREATS	HP:0002563	Constrictive Pericarditis					1
32726213	MAXO:0000376	Liver biopsy	TREATS	suspected cirrhosis		MONDO:0006711				1
32726213	MAXO:0010203	Echocardiography	DETECTS	thickened, calcified pericardium		MONDO:0006711				1
32726213	Chest computed tomography		DETECTS	thickened, calcified pericardium		Constrictive Pericarditis				1
37347440	Prompt diagnosis		PREVENTS	Organ failure		Pediatric Acute-on-Chronic Liver Failure				1
37347440	Medical management of a potentially treatable etiology of underlying cirrhosis		TREATS	Systemic inflammation		Pediatric Acute-on-Chronic Liver Failure				1
37347440	Bridging therapies		TREATS	HP:0100806	Sepsis	Pediatric Acute-on-Chronic Liver Failure				1
37347440	High volume plasma exchange		TREATS	Organ failure		Pediatric Acute-on-Chronic Liver Failure	High volume	plasma exchange		1
37347440	Liver transplantation		TREATS	Organ failure		Pediatric Acute-on-Chronic Liver Failure				1
35255304	Early diagnosis		PREVENTS	progression		MONDO:0005071				1
35255304	Elevated serum levels		INDICATES	Neurological diseases				Glial fibrillary acidic protein (GFAP)		1
32544364	treatment		TREATS	Wilson disease		MONDO:0010200	with Triethylenetetramine	CHEBI:39501		1
32544364	induction of autophagy		PREVENTS	weight gain		mice fed a high-fat diet		autophagy		1
32544364	reduction of weight gain		TREATS	HP:0004324	weight gain	mice fed a high-fat diet				1
34908013	MAXO:0001175	liver transplantation	TREATS	HP:0001399	Hepatic failure	Acutely Decompensated Hepatic Wilson Disease				1
34908013	Liver transplantation		TREATS	Encephalopathy		Acutely Decompensated Hepatic Wilson Disease				1
34908013	Chelation therapy		PREVENTS	liver transplantation		Acutely Decompensated Hepatic Wilson Disease				1
34908013	Cohort analysis		TREATS	Acutely Decompensated Hepatic Wilson Disease						1
34908013	Monitoring		TREATS	Acutely Decompensated Hepatic Wilson Disease						1
34435331	neuropsychiatric evaluation		TREATS	HP:0100543	cognitive impairment	MONDO:0010200	using	Neuropsychiatric Inventory (NPI) battery		1
34435331	Cranial MRI		TREATS	HP:0100022	Movement disorders	MONDO:0010200				1
34435331	measurement of serum glutamate level		TREATS	HP:0000713	agitation	MONDO:0010200	with serum glutamate	CHEBI:29987		1
34435331	Cranial MRI		TREATS	appetite change		MONDO:0010200				1
34435331	neuropsychiatric evaluation using Neuropsychiatric Inventory (NPI) battery		TREATS	elation		MONDO:0010200				1
34435331	neuropsychiatric evaluation		TREATS	irritability		Wilson Disease		Neuropsychiatric Inventory (NPI) battery		1
34435331	Cranial MRI		TREATS	HP:0000739	anxiety	MONDO:0010200				1
34435331	neuropsychiatric evaluation		TREATS	depression		Wilson Disease		Neuropsychiatric Inventory (NPI) battery		1
34435331	Cranial MRI		TREATS	HP:0000741	apathy	MONDO:0010200				1
34435331	neuropsychiatric evaluation		TREATS	night time abnormal behavior		MONDO:0010200	using	Neuropsychiatric Inventory (NPI) battery		1
34435331	neuropsychiatric evaluation		TREATS	aberrant motor behavior		MONDO:0010200	using	Neuropsychiatric Inventory (NPI) battery		1
34435331	neuropsychiatric evaluation		TREATS	HP:0000746	delusions	MONDO:0010200		Neuropsychiatric Inventory (NPI) battery		1
34435331	neuropsychiatric evaluation using Neuropsychiatric Inventory (NPI) battery		TREATS	HP:0000738	hallucination	MONDO:0010200				1
33785637	Testing		PREVENTS	misdiagnosis		MONDO:0013209		autoimmune hepatitis	NAFLD	1
33785637	Testing for Wilson disease		PREVENTS	misdiagnosis		MONDO:0013209				1
33785637	Testing for viral hepatitis B and C		PREVENTS	misdiagnosis		NAFLD		viral hepatitis B and C testing		1
33785637	Testing		PREVENTS	Misdiagnosis		NAFLD		thyroid dysfunction		1
33785637	Testing for celiac disease		PREVENTS	misdiagnosis		MONDO:0013209				1
33785637	Testing for alpha-1 antitrypsin deficiency		PREVENTS	misdiagnosis		MONDO:0013209		alpha-1 antitrypsin		1
33785637	Testing for hemochromatosis		PREVENTS	misdiagnosis		MONDO:0013209				1
33785637	Liver biopsy		TREATS	Elevated serum aminotransferases		NAFLD	NA	NA	NA	1
33785637	MAXO:0000376	Liver biopsy	TREATS	HP:0001397	Hepatic steatosis	MONDO:0013209				1
32401363	transient elastography		TREATS	biochemical abnormality		MONDO:0010200				1
32401363	2-dimensional (2D) shear wave elastography		TREATS	biochemical abnormality		MONDO:0010200				1
32401363	calculation of aspartate transaminase-to-platelet ratio index (APRI)		TREATS	biochemical abnormality		MONDO:0010200				1
32401363	calculation of Fibrosis-4 (FIB-4) score		TREATS	biochemical abnormality		Wilson Disease		Fibrosis-4 (FIB-4) score		1
32401363	combining serologic markers with US elastography		TREATS	biochemical abnormality		MONDO:0010200		serologic markers, US elastography		1
32401363	transient elastography		TREATS	altered hepatic morphologic characteristics		Wilson Disease		transient elastography	altered hepatic morphologic characteristics	1
32401363	2-dimensional (2D) shear wave elastography		TREATS	altered hepatic morphologic characteristics		Wilson Disease		2-dimensional (2D) shear wave elastography		1
32401363	calculation of aspartate transaminase-to-platelet ratio index (APRI)		TREATS	altered hepatic morphologic characteristics		MONDO:0010200				1
32401363	calculation of Fibrosis-4 (FIB-4) score		TREATS	altered hepatic morphologic characteristics		MONDO:0010200				1
32401363	combining serologic markers with US elastography		TREATS	altered hepatic morphologic characteristics		MONDO:0010200		serologic markers with US elastography		1
32401363	transient elastography		TREATS	compensated liver cirrhosis		MONDO:0010200				1
32401363	2-dimensional (2D) shear wave elastography		TREATS	liver cirrhosis		Wilson Disease		2-dimensional (2D) shear wave elastography	compensated	1
32401363	calculation of aspartate transaminase-to-platelet ratio index (APRI)		TREATS	compensated liver cirrhosis		Wilson Disease		aspartate transaminase-to-platelet ratio index (APRI)		1
32401363	calculation		TREATS	compensated liver cirrhosis		Wilson Disease		Fibrosis-4 (FIB-4) score		1
32401363	combining serologic markers with US elastography		TREATS	compensated liver cirrhosis		MONDO:0010200		US elastography		1
31222986	Switching D-penicillamine to trientine		PREVENTS	recurrence		ANCA-associated Vasculitis		trientine		1
31222986	Plasmapheresis		TREATS	pulmonary hemorrhage		ANCA-associated Vasculitis			diffuse	1
31222986	MAXO:0001298	therapy	TREATS	HP:0040223	pulmonary hemorrhage	MONDO:0012105		CHEBI:24261	diffuse	1
31222986	administration		TREATS	HP:0000790	hematuria	MONDO:0012105		CHEBI:4027	microscopic	1
31222986	administration		TREATS	HP:0000093	Proteinuria	MONDO:0012105		CHEBI:8764		1
31899725	MAXO:0000127	genetic testing	PREVENTS	asymptomatic		MONDO:0010200				1
31899725	evidence-based management		TREATS	asymptomatic		MONDO:0010200				1
31899725	algorithmic approach to management		TREATS	asymptomatic		MONDO:0010200				1
38081365	Treatment		TREATS	copper accumulation in the liver		MONDO:0010200		Bis-choline tetrathiomolybdate		1
38081365	Treatment		TREATS	copper accumulation in the brain		MONDO:0010200		Bis-choline tetrathiomolybdate		1
38081365	Oral administration		PREVENTS	copper accumulation in the liver		healthy volunteers		64Cu		1
38081365	Intravenous dosing		PREVENTS	copper accumulation		MONDO:0010200		64Cu		1
28435998	MAXO:0000376	liver biopsy	TREATS	progressive abdominal distension		MONDO:0010200				1
28435998	MAXO:0000376	liver biopsy	TREATS	HP:0000952	jaundice	MONDO:0010200				1
28435998	gene studies		TREATS	HP:0000952	jaundice	MONDO:0010200	with D-pencillamine	D-pencillamine		1
28435998	gene studies		TREATS	progressive abdominal distension		MONDO:0010200				1
33159804	Serum ceruloplasmin determination		PREVENTS	evolution of Wilson disease		Wilson disease		ceruloplasmin		1
33159804	Genetic screening		PREVENTS	evolution of Wilson disease		MONDO:0010200				1
33159804	Population screening		PREVENTS	evolution of Wilson disease		MONDO:0010200				1
28284465	Neurological evaluation		TREATS	Compromised liver function		Neurological disorders in liver transplant candidates				1
28284465	Pre-transplant neurological assessment		TREATS	Systemic inflammation		Neurological disorders in liver transplant candidates				1
28284465	Biochemical diagnostic tools		TREATS	Brain damage		Neurological disorders in liver transplant candidates		Biochemical diagnostic tools		1
28284465	Neurophysiological diagnostic tools		TREATS	HP:0002480	hepatic encephalopathy	Neurological disorders in liver transplant candidates				1
28284465	Neuropsychological diagnostic tools		TREATS	Diffuse cerebral edema		Neurological disorders in liver transplant candidates				1
28284465	Neuroimaging diagnostic tools		TREATS	Acquired hepatocerebral degeneration		Neurological disorders in liver transplant candidates		Neuroimaging diagnostic tools		1
31276461	Scheimpflug-based tomography		TREATS	HP:0200032	Kayser-Fleischer rings	MONDO:0010200				1
31276461	MAXO:0000973	slit-lamp examination	TREATS	HP:0200032	Kayser-Fleischer rings	MONDO:0010200				1
31276461	densitometry analysis		TREATS	Kayser-Fleischer rings		Wilson disease				1
31276461	ImageJ analysis		TREATS	HP:0200032	Kayser-Fleischer rings	MONDO:0010200				1
31276461	ImageJ analysis		MONITORS	disease progression		MONDO:0010200				1
29325220	liver transplant		TREATS	HP:0001919	acute kidney injury	acute-on-chronic liver failure				1
29325220	higher baseline bilirubin		INDICATES	HP:0001919	acute kidney injury	acute-on-chronic liver failure				1
29325220	higher international normalized ratio		INDICATES	acute kidney injury		acute-on-chronic liver failure				1
29325220	presence of systemic inflammatory response syndrome		INDICATES	HP:0001919	acute kidney injury	acute-on-chronic liver failure				1
29325220	presence of spontaneous bacterial peritonitis		INDICATES	HP:0001919	acute kidney injury	acute-on-chronic liver failure				1
29325220	death		RESULTS FROM	acute kidney injury		acute-on-chronic liver failure				1
36422847	Plugged percutaneous liver biopsy		TREATS	inadequate coiling causing mild hemoperitoneum		Percutaneous liver biopsy complications		Tru-cut needle and coils		1
36422847	ultrasonography (USG) guidance		TREATS	arterioportal fistula		Percutaneous liver biopsy complications				1
36422847	ultrasonography (USG) guidance		TREATS	HP:0002107	pneumothorax	Percutaneous liver biopsy complications				1
36422847	repeat study		TREATS	Percutaneous liver biopsy complications		suspected underlying liver disease				1
36422847	histopathological examination		TREATS	Percutaneous liver biopsy complications		MONDO:0016264				1
36422847	histopathological examination		TREATS	cirrhotic changes		Percutaneous liver biopsy complications				1
36422847	histopathological examination		TREATS	HP:0025322	veno-occlusive disease	Percutaneous liver biopsy complications				1
36422847	histopathological examination		TREATS	cholestatic disease		Percutaneous liver biopsy complications				1
36422847	histopathological examination		TREATS	Percutaneous liver biopsy complications		MONDO:0010200				1
28495941	Measurement of the MR Parkinsonism index and its indices using the 3D BRAVO T1 sequence		TREATS	Pontomesencephalic involvement		Wilson Disease		MR Parkinsonism index		1
28495941	Measurement of the MR Parkinsonism index and its indices using the 3D BRAVO T1 sequence		TREATS	Postural reflex abnormality		MONDO:0010200				1
28495941	Measurement of the MR Parkinsonism index and its indices using the 3D BRAVO T1 sequence		TREATS	Midbrain atrophy		MONDO:0010200				1
28495941	Measurement of the MR Parkinsonism index and its indices		TREATS	Neurologic severity		MONDO:0010200		3D BRAVO T1 sequence		1
28495941	Measurement of the MR Parkinsonism index and its indices		TREATS	Abnormal postural reflex		Wilson Disease		3D BRAVO T1 sequence		1
28433114	liver disease screening		PREVENTS	HP:0200120	chronic active hepatitis	MONDO:0010200				1
28433114	liver disease screening		PREVENTS	end-stage liver disease with cirrhosis		Wilson disease				1
28433114	liver disease screening		PREVENTS	HP:0006554	Acute Liver Failure	MONDO:0010200				1
28433114	family screening		PREVENTS	HP:0200120	chronic active hepatitis	MONDO:0010200				1
28433114	family screening		PREVENTS	end-stage liver disease		Wilson disease		family screening	with cirrhosis	1
28433114	family screening		PREVENTS	HP:0006554	Acute Liver Failure	MONDO:0010200	N/A	N/A	N/A	1
28433114	routine laboratory testing		PREVENTS	HP:0200120	chronic active hepatitis	MONDO:0010200				1
28433114	routine laboratory testing		PREVENTS	end-stage liver disease with cirrhosis		MONDO:0010200				1
28433114	routine laboratory testing		PREVENTS	HP:0006554	Acute Liver Failure	MONDO:0010200				1
28433114	initiation of appropriate therapy		TREATS	biliary copper excretion		MONDO:0010200		appropriate therapy		1
28433114	initiation of appropriate therapy		TREATS	pathologic copper accumulation		Wilson disease		appropriate therapy	pathologic copper accumulation	1
28433114	initiation of appropriate therapy		TREATS	cellular damage		Wilson disease		appropriate therapy		1
28433114	initiation of appropriate therapy		TREATS	HP:0200120	chronic active hepatitis	MONDO:0010200				1
28433114	initiation of appropriate therapy		TREATS	end-stage liver disease with cirrhosis		MONDO:0010200				1
28433114	initiation of appropriate therapy		TREATS	HP:0006554	Acute Liver Failure	MONDO:0010200				1
28433114	initiation of appropriate therapy		PREVENTS	HP:0002896	liver cancer	MONDO:0010200				1
32398360	Liver transplant		TREATS	neurologic Wilson disease						1
29979436	Familial screening		PREVENTS	No clinical symptoms		Wilson disease				1
29979436	MAXO:0000527	Physical examination	PREVENTS	No clinical symptoms		MONDO:0010200				1
29979436	K-F rings check		PREVENTS	No clinical symptoms		Wilson disease		K-F rings check	No clinical symptoms	1
29979436	MAXO:0010200	Abdominal ultrasonography (Abdl Ur)	PREVENTS	No clinical symptoms		MONDO:0010200				1
29979436	Cranial magnetic resonance imaging		PREVENTS	No clinical symptoms		Wilson disease		MRI		1
29979436	Serum ceruloplasmin test		TREATS	HP:0010837	Decreased serum ceruloplasmin	MONDO:0010200	with Ceruloplasmin	Ceruloplasmin		1
29979436	Serum copper test		TREATS	Decreased serum copper		MONDO:0010200	with Copper	CHEBI:28694		1
29979436	24-hour urine copper test		TREATS	Increased urine copper		Wilson disease	null	null	null	1
29979436	Blood alanine transaminase (ALT) test		TREATS	Liver function abnormalities		MONDO:0010200	with Alanine transaminase	Alanine transaminase		1
29979436	Aspartate transaminase (AST) test		TREATS	Liver function abnormalities		MONDO:0010200	with Aspartate transaminase	Aspartate transaminase		1
29979436	ATP7B gene sequencing		TREATS	Compound heterozygous mutations		MONDO:0010200		ATP7B gene sequencing	Compound heterozygous mutations	1
29979436	MAXO:0000127	Genetic analysis	PREVENTS	No clinical symptoms		MONDO:0010200				1
29381936	Detailed physical examination		TREATS	Isolated disabling premature osteoarthritis		MONDO:0010200				1
29381936	Special biochemical test		TREATS	Isolated disabling premature osteoarthritis		Wilson disease		Special biochemical test		1
29381936	Genotyping		TREATS	Isolated disabling premature osteoarthritis		MONDO:0010200		CHEBI:28787		1
36343759	injection		TREATS	lower limb dystonia		MONDO:0010200		CHEBI:3160		1
36343759	Clinical scales evaluation		ASSESSES	lower limb dystonia		MONDO:0010200				1
36343759	Surface electromyography (EMG)		ASSESSES	lower limb dystonia		MONDO:0010200				1
36343759	Gait analysis		ASSESSES	lower limb dystonia		MONDO:0010200				1
28602929	MAXO:0000127	Genetic analysis	TREATS	Hereditary Multiple Cerebral Cavernous Malformations						1
38171926	Liver-directed gene therapy		TREATS	inherited metabolic liver diseases				gene therapy		1
38171926	Gene editing		TREATS	inherited metabolic liver diseases						1
38171926	Viral gene therapy		TREATS	inherited metabolic liver diseases						1
38171926	Nonviral gene therapy		TREATS	inherited metabolic liver diseases			Nonviral	gene therapy	inherited metabolic liver diseases	1
31421978	MAXO:0000376	liver biopsy	TREATS	hepatic manifestations		MONDO:0010200				1
31421978	genetic testing and sequencing		PREVENTS	misdiagnosis		MONDO:0010200				1
31421978	MAXO:0000376	liver biopsy	TREATS	abnormal liver tests		MONDO:0010200				1
31421978	MAXO:0000376	liver biopsy	TREATS	HP:0200123	chronic hepatitis	MONDO:0010200				1
31421978	MAXO:0000376	liver biopsy	TREATS	HP:0001397	steatosis	MONDO:0010200	with copper staining	copper staining		1
31421978	MAXO:0000376	liver biopsy	TREATS	steatohepatitis		MONDO:0010200	with copper staining	copper staining		1
29961769	Early diagnosis		PREVENTS	worsening of condition		Treatable Inherited Disorders (TIDs)				1
29961769	Genomic studies		TREATS	lack of ethnicity-specific data		Treatable Inherited Disorders (TIDs)		Genomic studies		1
29961769	Exome/genome sequencing		TREATS	unidentified genetic variants		Treatable Inherited Disorders (TIDs)				1
29961769	Disease causing variants analysis		TREATS	undiagnosed genetic conditions		Treatable Inherited Disorders (TIDs)				1
36524887	Orthotopic liver transplant		TREATS	neurological symptoms		MONDO:0010200				1
36524887	Evaluation with neurological scoring systems		PREVENTS	neurological symptoms		MONDO:0010200				1
33057522	measuring the 65Cu/63Cu ratios		PREVENTS	undiagnosed Wilson disease		MONDO:0010200				1
33057522	treatment with d-penicillamine		TREATS	accumulation of Cu in the liver		MONDO:0010200		CHEBI:7959		1
33057522	treatment		TREATS	accumulation of Cu in the liver		MONDO:0010200		CHEBI:39501		1
33057522	measuring the Cu concentrations		TREATS	undiagnosed Wilson disease		MONDO:0010200		Cu concentrations		1
30836904	Liver transplant		TREATS	HP:0100626	End-stage liver diseases	MONDO:0017014				1
30836904	Liver transplant		TREATS	HP:0000952	jaundice	MONDO:0100193				1
30836904	Liver transplant		TREATS	HP:0001541	Ascites	MONDO:0100193				1
30836904	Liver transplant		TREATS	HP:0002040	Esophageal varices	MONDO:0100193				1
31884064	MAXO:0001175	liver transplantation	TREATS	Wilson Disease (WD)						1
31884064	Dynamic liver CT examination		TREATS	contour irregularity		MONDO:0010200		Dynamic liver CT examination		1
31884064	Dynamic liver CT examination		TREATS	hepatic dysmorphia		MONDO:0010200				1
31884064	Dynamic liver CT examination		TREATS	periportal thickening		MONDO:0010200				1
31884064	Dynamic liver CT examination		TREATS	HP:0001081	Cholelithiasis	MONDO:0010200				1
31884064	Dynamic liver CT examination		TREATS	splenomegaly		MONDO:0010200		Dynamic liver CT examination		1
31884064	Dynamic liver CT examination		TREATS	lymphadenopathy		MONDO:0010200				1
31884064	Dynamic liver CT examination		TREATS	portosystemic shunting		MONDO:0010200				1
31884064	Dynamic liver CT examination		TREATS	hyperdense nodules		MONDO:0010200				1
31884064	Dynamic liver CT examination		TREATS	honeycomb pattern		MONDO:0010200				1
31884064	Dynamic liver CT examination		TREATS	hypertrophy of caudate lobe		MONDO:0010200		Dynamic liver CT examination	hypertrophy of caudate lobe	1
31897936	infrared videooculography		TREATS	prolonged latencies of horizontal prosaccades		MONDO:0010200		infrared videooculography		1
31897936	infrared videooculography		TREATS	hypometry of both horizontal and vertical prosaccades		MONDO:0010200				1
31897936	infrared videooculography		TREATS	prolonged latency of both horizontal and vertical antisaccades		MONDO:0010200				1
31897936	infrared videooculography		TREATS	increased error rate of vertical antisaccades		MONDO:0010200				1
31897936	MRI		TREATS	HP:0007366	brainstem atrophy	MONDO:0010200				1
31897936	treatment		TREATS	Wilson disease		MONDO:0010200		anti-copper		1
33754827	long-term anti-copper treatment		TREATS	HP:0012444	brain atrophy	MONDO:0010200	long-term	anti-copper treatment		1
33754827	long-term anti-copper treatment		TREATS	cerebral iron accumulation		MONDO:0010200	long-term	anti-copper treatment		1
37074913	cryoelectron microscopy (cryo-EM) structures analysis		TREATS	Wilson disease				cryoelectron microscopy		1
37074913	development of therapeutics		TREATS	Wilson disease			with copper	CHEBI:28694		1
37634880	pre-symptomatic screening		PREVENTS	HP:0006554	acute liver failure	MONDO:0010200				1
37634880	genetic newborn screening		PREVENTS	elevated aminotransferase levels		Wilson disease		genetic newborn screening		1
37634880	early treatment		TREATS	extremely low serum ceruloplasmin level		MONDO:0010200				1
29806946	Assessment of non-ceruloplasmin-bound copper (NCC) levels in blood		TREATS	Excess toxic copper accumulation		MONDO:0010200		non-ceruloplasmin-bound copper (NCC)		1
29806946	Oral administration		TREATS	Excess toxic copper accumulation		MONDO:0010200	with WTX101	WTX101		1
29806946	Lowering NCC levels		TREATS	Excess toxic copper accumulation		MONDO:0010200		WTX101		1
29806946	Improved neurological status		TREATS	Severe and life-threatening symptoms		MONDO:0010200	with WTX101	WTX101		1
29806946	Reduced disability		TREATS	symptoms		MONDO:0010200		WTX101	Severe and life-threatening	1
29806946	Stable liver function		PREVENTS	Severe and life-threatening symptoms		MONDO:0010200	with WTX101	WTX101		1
29806946	Biliary copper excretion		TREATS	Excess toxic copper accumulation		MONDO:0010200	with WTX101	WTX101		1
29715505	copper		TREATS	dose-dependent reduced capacity to produce ATP		MONDO:0010200		CHEBI:28694		1
29715505	TREATS		TREATS	increased production of reactive oxygen species		MONDO:0010200		CHEBI:28694		1
33181595	Visual evoked potentials (VEP) assessment		TREATS	Abnormal evoked responses		MONDO:0010200				1
33181595	Brainstem auditory evoked potentials (BAEP) assessment		TREATS	Abnormal evoked responses		MONDO:0010200				1
33181595	Visual evoked potentials (VEP) assessment		TREATS	Prolongation		Wilson disease		VEP	of the latencies of the III and V waves	1
33181595	Brainstem auditory evoked potentials (BAEP) assessment		TREATS	Prolongation of the latencies of the III and V waves		MONDO:0010200	none	none	none	1
33181595	Visual evoked potentials (VEP) assessment		TREATS	Abnormal VEP		MONDO:0010200				1
33181595	Brainstem auditory evoked potentials (BAEP) assessment		TREATS	Abnormal BAEP		MONDO:0010200				1
30026388	Diagnostic whole-exome sequencing		IDENTIFIES	Wilson disease		patient		whole-exome sequencing		1
30026388	Lifestyle counseling		TREATS	NAFLD		Wilson disease		Lifestyle counseling	NAFLD	1
30026388	Treatment		TREATS	Wilson disease		patient	with d-penicillamine	CHEBI:7959		1
30026388	24 h urine copper quantification		CONFIRMS	Wilson disease		patient				1
33662781	monotherapy		TREATS	abnormal alanine transaminase/aspartate transaminase levels		MONDO:0010200		CHEBI:27363		1
33662781	Follow up liver function tests		TREATS	uncontrolled serum liver enzyme levels		MONDO:0010200				1
33662781	Combination treatment		TREATS	uncontrolled serum liver enzyme levels		MONDO:0010200		CHEBI:38161		1
33662781	Serum aminotransferase level measurement		TREATS	abnormal alanine transaminase/aspartate transaminase levels		MONDO:0010200				1
31152642	Immunosuppression treatment		PREVENTS	HP:0006554	Acute Liver Failure	Non-Hodgkin B-cell lymphoma (NHBCL)	with cyclosporine A	cyclosporine A		1
31152642	Anti-neoplastic polychemotherapy treatment		TREATS	HP:0002665	Lymphoma	Non-Hodgkin B-cell lymphoma (NHBCL)		Polychemotherapy	High-grade	1
31152642	r-CHOP protocol		TREATS	high-grade lymphoma		Non-Hodgkin B-cell lymphoma		rituximab and CHOP therapy		1
33541020	drug therapy		TREATS	copper excretion disorders		MONDO:0010200		drug therapy		1
33541020	MAXO:0001175	liver transplantation	TREATS	poor drug response		MONDO:0010200				1
33541020	MAXO:0001175	liver transplantation	TREATS	HP:0006554	acute liver failure	MONDO:0010200		liver transplantation		1
33541020	MAXO:0001001	gene therapy	TREATS	copper excretion disorders		MONDO:0010200				1
31920114	Switching Pharmacological Treatment		TREATS	Liver enzyme fluctuations		MONDO:0010200	with Penicillamine	CHEBI:50868		1
31920114	Switching Pharmacological Treatment		TREATS	Liver enzyme fluctuations		MONDO:0010200	with Trientine	CHEBI:39501		1
31920114	Monitoring Liver Enzymes		TREATS	Liver enzyme fluctuations		MONDO:0010200				1
31920114	Monitoring 24-hour		PREVENTS	complications		Wilson Disease		Urine Copper	longterm complications	1
31920114	Switching Pharmacological Treatment		TREATS	HP:0001919	acute renal failure	MONDO:0010200	with Penicillamine	CHEBI:50868		1
37996345	therapeutic plasma exchange		TREATS	deranged metabolism		acute liver failure		therapeutic plasma exchange		1
37996345	therapeutic plasma exchange		TREATS	encephalopathy		acute liver failure		therapeutic plasma exchange		1
37996345	therapeutic plasma exchange (TPE)		TREATS	coagulopathy		acute liver failure				1
37996345	therapeutic plasma exchange (TPE)		TREATS	worsening liver parameters		acute liver failure		CHEBI:30360		1
37996345	liver transplant		TREATS	HP:0006554	acute liver failure					1
32228506	Phlebotomy treatment		TREATS	T2/T2*GRE-hypointensity		Idiopathic brain calcification	with Vitamin D	CHEBI:27300		1
32228506	Brain-MRI		TREATS	T2/T2*GRE-hypointensity		Idiopathic brain calcification				1
32228506	MAXO:0000571	Brain computed tomography (CT)	TREATS	T2/T2*GRE-hypointensity		Idiopathic brain calcification				1
32228506	DNA sequence analysis		TREATS	Idiopathic brain calcification						1
32228506	Measurement of serum ceruloplasmin and copper, and urinary copper		TREATS	T2/T2*GRE-hypointensity		Idiopathic brain calcification		ceruloplasmin and copper	T2/T2*GRE-hypointensity	1
34047646	Serum ceruloplasmin monitoring		TREATS	HP:0010837	Hypoceruloplasminemia	Silver intoxication		ceruloplasmin		1
34047646	Silver cessation		TREATS	sensory and gait problems		Silver intoxication		Silver cessation		1
34047646	cessation		TREATS	deranged liver function tests		Silver intoxication		CHEBI:30512		1
34047646	Silver cessation		TREATS	distorted acinar architecture		Silver intoxication		Silver cessation		1
34047646	cessation		TREATS	bridging fibrosis		Silver intoxication		CHEBI:30512		1
34047646	Silver cessation		TREATS	lymphocytic infiltrate		Silver intoxication				1
34047646	Silver cessation		TREATS	mineralization over bilateral globus pallidi		Silver intoxication		Silver cessation		1
34047646	Silver cessation		TREATS	HP:0011734	Central adrenal insufficiency	Silver intoxication		Silver cessation		1
34047646	Silver cessation		TREATS	intracellular iron overload		Silver intoxication		Silver cessation		1
34047646	cessation		TREATS	HP:0010837	Hypoceruloplasminemia	Silver intoxication		CHEBI:30512		1
32745371	chelation therapy		TREATS	hepatocellular dysfunction		MONDO:0010200		chelation		1
32745371	chelation therapy		TREATS	HP:0001409	portal hypertension	MONDO:0010200				1
32745371	monotherapy		TREATS	HP:0001392	Liver disease	MONDO:0010200		CHEBI:7959	severe	1
32745371	treatment		TREATS	severe liver disease		MONDO:0010200		D-penicillamine and zinc		1
32745371	MAXO:0001193	upper endoscopy	PREVENTS	complications		MONDO:0010200				1
32745371	therapeutic endoscopic sessions		TREATS	HP:0002040	esophageal varices	MONDO:0010200				1
32745371	prophylaxis		PREVENTS	complications		MONDO:0010200				1
32181965	developing and validating a brain MRI visual rating scale		PREVENTS	T2 hyperintensities		MONDO:0010200				1
32181965	developing and validating a brain MRI visual rating scale		PREVENTS	T2 hypointensities		MONDO:0010200				1
32181965	developing and validating a brain MRI visual rating scale		PREVENTS	HP:0012444	brain atrophy	MONDO:0010200				1
32181965	treatment		TREATS	T2 hyperintensities		MONDO:0010200		anticopper		1
32624691	comparison of liver function		TREATS	Impaired Hepatic Synthesis		Cirrhosis in Wilson Disease				1
32624691	comparison of portal hypertension features		TREATS	wider portal vein diameter		Cirrhosis in Wilson Disease				1
32624691	comparison of portal hypertension features		TREATS	splenomegaly/splenectomy		Cirrhosis in Wilson Disease		portal hypertension features		1
32624691	comparison of hematocytopenia rates		TREATS	Leukopenia		Cirrhosis in Wilson Disease		hematocytopenia rates		1
32624691	comparison of hematocytopenia rates		TREATS	Thrombocytopenia		Cirrhosis in Wilson Disease				1
33097693	Prime editing		TREATS	proliferation		MONDO:0002691		Prime editing		1
33097693	Prime editing		TREATS	mutations		DGAT1-deficiency				1
33097693	Prime editing		TREATS	mutations		MONDO:0010200				1
33097693	Base editing		TREATS	genetic defects		disease (generic, not disease-specific due to lack of detail)		Base editing		1
34286869	examination by a cardiologist		TREATS	HP:0001638	cardiomyopathy	MONDO:0010200				1
34286869	MAXO:0000900	ECG	TREATS	HP:0003115	electrocardiogram (ECG) abnormalities	MONDO:0010200				1
34286869	monitoring of cardiac biomarkers		TREATS	increased levels of troponin		MONDO:0010200				1
34286869	MAXO:0010203	Echocardiography	TREATS	left ventricular (LV) remodeling		MONDO:0010200				1
34286869	Holter monitoring		TREATS	rhythm or conduction abnormalities		MONDO:0010200	24-hours or more			1
34286869	cardiac magnetic resonance imaging		TREATS	HP:0001638	cardiomyopathy	MONDO:0010200				1
28987255	MAXO:0000127	Genetic analysis	TREATS	Mildly abnormal liver tests		MONDO:0005154				1
28987255	MAXO:0000127	Genetic analysis	TREATS	HP:0006554	Acute Liver Failure	MONDO:0005154				1
35706098	Chelation therapy		TREATS	Wilson's disease						1
35706098	Determining 24-hour urinary copper excretion levels		TREATS	Wilson's disease						1
35706098	Monitoring exchangeable copper levels		TREATS	Wilson's disease						1
29050651	MAXO:0000526	Clinical examination	TREATS	HP:0001337	Tremor	MONDO:0005395				1
29050651	MAXO:0000526	Clinical examination	TREATS	HP:0002072	Chorea	MONDO:0005395				1
29050651	MAXO:0000526	Clinical examination	TREATS	HP:0001332	Dystonia	MONDO:0005395				1
29050651	MAXO:0000526	Clinical examination	TREATS	HP:0100033	Tics	MONDO:0005395				1
29050651	MAXO:0000526	Clinical examination	TREATS	HP:0001336	Myoclonus	MONDO:0005395				1
29050651	Symptomatic therapeutic management		TREATS	HP:0001337	Tremor	MONDO:0005395				1
29050651	Symptomatic therapeutic management		TREATS	HP:0002072	Chorea	MONDO:0005395				1
29050651	Symptomatic therapeutic management		TREATS	HP:0001332	Dystonia	MONDO:0005395				1
29050651	Symptomatic therapeutic management		TREATS	HP:0100033	Tics	MONDO:0005395				1
29050651	Symptomatic therapeutic management		TREATS	HP:0001336	Myoclonus	MONDO:0005395				1
29050651	Prescription		TREATS	Tremor		Movement disorders		specific oral drugs		1
29050651	Prescription		TREATS	Chorea		Movement disorders		specific oral drugs		1
29050651	Prescription		TREATS	HP:0001332	Dystonia	MONDO:0005395		specific oral drugs		1
29050651	Prescription		TREATS	Tics		Movement disorders		specific oral drugs		1
29050651	Prescription		TREATS	HP:0001336	Myoclonus	MONDO:0005395	specific	specific oral drugs		1
29050651	Radiosurgery		TREATS	HP:0001337	Tremor	MONDO:0005395				1
29050651	MAXO:0000943	Deep brain stimulation	TREATS	HP:0001337	Tremor	MONDO:0005395				1
29050651	MAXO:0000943	Deep brain stimulation	TREATS	HP:0007325	Generalized dystonia	MONDO:0005395				1
30893721	treatment		TREATS	neurological symptoms		MONDO:0010200		CHEBI:50868		1
30893721	treatment		TREATS	HP:0001410	Hepatic dysfunction	MONDO:0010200		CHEBI:50868		1
30893721	treatment		TREATS	neurological symptoms		MONDO:0010200		CHEBI:29708		1
30893721	treatment		TREATS	HP:0001410	Hepatic dysfunction	MONDO:0010200		CHEBI:29708		1
30893721	treatment		TREATS	HP:0002910	elevated transaminases	MONDO:0010200		CHEBI:50868		1
30893721	treatment		TREATS	HP:0002910	elevated transaminases	MONDO:0010200		CHEBI:29708		1
30893721	treatment (with copper)		INCREASES	urinary copper		MONDO:0010200		CHEBI:50868		1
30693797	Copper chelation therapy		TREATS	severe liver damage		MONDO:0010200		Copper chelation therapy		1
30693797	Intravenous administration		TREATS	decreased liver copper levels		MONDO:0010200		adeno-associated viral (AAV) 8 vector		1
30693797	Intravenous administration		TREATS	HP:0001392	Hepatic disease	MONDO:0010200		adeno-associated viral (AAV) 8 vector		1
30693797	Intravenous administration		PREVENTS	HP:0001395	Liver fibrosis	MONDO:0010200		adeno-associated viral (AAV) 8 vector		1
34357516	Chelation of excessive copper		TREATS	copper metabolism disorder		MONDO:0010200		chelation		1
34357516	Oral administration		TREATS	copper metabolism disorder		MONDO:0010200		trientine tetrahydrochloride		1
34357516	Oral administration		TREATS	copper metabolism disorder		MONDO:0010200		trientine dihydrochloride		1
28753182	Analysis of clinical presentations, diagnosis, and treatment		TREATS	Abnormal liver function test results		MONDO:0010200				1
28753182	Serum alanine aminotransferase level testing		TREATS	Abnormal liver function test results		Wilson Disease		alanine aminotransferase		1
28753182	Serum aspartate aminotransferase level testing		TREATS	Abnormal liver function test results		Wilson Disease		Serum aspartate aminotransferase level testing		1
28753182	Serum ceruloplasmin concentration testing		TREATS	Abnormal liver function test results		MONDO:0010200		ceruloplasmin concentration testing		1
28753182	Urinary copper excretion testing		TREATS	Abnormal liver function test results		MONDO:0010200				1
28753182	Liver copper quantification		TREATS	Abnormal liver function test results		MONDO:0010200				1
28753182	Treatment		TREATS	Abnormal liver function test results		MONDO:0010200		zinc salts		1
28753182	Treatment		TREATS	Abnormal liver function test results		MONDO:0010200		CHEBI:7959		1
28433112	MAXO:0000376	liver biopsy	TREATS	HP:0004787	Fulminant hepatitis	MONDO:0010200				1
28433112	MAXO:0000376	liver biopsy	TREATS	Moderate to severe steatosis		MONDO:0010200				1
28433112	MAXO:0000376	liver biopsy	TREATS	Portal and/or lobular inflammation		MONDO:0010200				1
28433112	MAXO:0000376	liver biopsy	TREATS	Fibrosis		MONDO:0010200				1
28433112	MAXO:0000376	liver biopsy	TREATS	Liver cell degeneration		MONDO:0010200				1
28433112	MAXO:0000376	liver biopsy	TREATS	Ballooning		MONDO:0010200				1
28433112	MAXO:0000376	liver biopsy	TREATS	Mallory hyaline bodies		MONDO:0010200				1
28433112	MAXO:0000376	liver biopsy	TREATS	Liver cell necrosis		MONDO:0010200				1
28433112	MAXO:0000376	liver biopsy	TREATS	Glycogenation of periportal hepatocytic nuclei		MONDO:0010200				1
30635971	anterior segment optical coherence tomography (AS-OCT) assessment		TREATS	HP:0200032	Kayser-Fleischer rings	MONDO:0010200				1
30635971	slit-lamp assessment		PREVENTS	early detection of corneal copper deposits		Wilson disease		slit-lamp assessment	corneal copper deposits	1
31728073	Genetic testing		TREATS	misdiagnosis		MONDO:0011214		Genetic testing		1
31728073	Molecular analysis		TREATS	misdiagnosis		MONDO:0011214		molecular analysis		1
31728073	Histopathological analysis		TREATS	misdiagnosis		MONDO:0011214				1
36459990	Diagnostic acumen		TREATS	Myriad manifestations		MONDO:0010200				1
36459990	Novel therapies		TREATS	Neurologic disorder		MONDO:0010200		Novel therapies		1
36459990	Novel therapies		TREATS	HP:0001392	Liver disease	MONDO:0010200				1
36459990	Diagnostic acumen		TREATS	Broad range of symptoms		Wilson Disease	null	null	null	1
28679132	Anterior Segment Optical Coherence Tomography Evaluation		TREATS	HP:0200032	Kayser-Fleischer rings	MONDO:0010200				1
31269566	chelating agents		TREATS	neurological symptoms		MONDO:0010200		CHEBI:38161		1
31269566	neural symptom scores assessment		TREATS	delayed onset		MONDO:0010200	modified	Young scale	delayed onset	1
31269566	grade of Child liver function assessment		TREATS	liver injury		Wilson disease		Child liver function assessment		1
31269566	mental symptoms rating scale assessment		TREATS	psychiatric symptoms		MONDO:0010200				1
31269566	magnetic resonance imaging (MRI) scan		TREATS	neurological symptoms		MONDO:0010200				1
31269566	susceptibility weighted imaging (SWI)		TREATS	neurological symptoms		MONDO:0010200				1
31269566	metal metabolism evaluation		PREVENTS	worsening		MONDO:0010200				1
30059866	Potentiometric determination		DETECTS	copper accumulation		Wilson disease		CHEBI:74067	copper accumulation	1
30059866	Application		DETECTS	copper accumulation		MONDO:0010200		carbon sensors		1
30059866	Use of modified screen printed electrode (MSPE)		DETECTS	copper accumulation		MONDO:0010200				1
30059866	Use of carbon paste electrode		DETECTS	copper accumulation		MONDO:0010200	MCPE	carbon paste electrode		1
37204330	oral medication		TREATS	Wilson disease						1
37204330	oral medication		PREVENTS	decline in activities of daily living (ADL)		MONDO:0010200		oral medication		1
37204330	oral medication		TREATS	hepatic symptoms with splenomegaly		MONDO:0010200		oral medication		1
37204330	oral medication		TREATS	neurological signs		MONDO:0010200				1
37204330	oral medication		TREATS	psychiatric presentation		MONDO:0010200		oral medication		1
32844772	Transient Elastography		REPRESENTS	Hepatic Copper Accumulation		MONDO:0010200				1
28433104	Strict adherence to decoppering agents		PREVENTS	impairment of liver function		MONDO:0010200		decoppering agents	symptomatic	1
28433104	Strict adherence to decoppering agents		PREVENTS	HP:0001394	Cirrhosis	MONDO:0010200		decoppering agents		1
28433104	Avoidance of other toxic substances		PREVENTS	additional hepatic damage		MONDO:0010200				1
28433104	Treatment		PREVENTS	HP:0001409	portal hypertension	MONDO:0010200	with nonselective beta-blockers	nonselective beta-blockers		1
28433104	Variceal ligation		PREVENTS	portal hypertension (esophagus varices)		Wilson disease				1
28433104	Treatment		TREATS	HP:0001541	Ascites	MONDO:0010200	with	CHEBI:35498		1
28433104	Treatment with antibiotics		TREATS	spontaneous bacterial peritonitis		Wilson disease		antibiotics		1
28433104	Treatment with laxatives		TREATS	HP:0002480	hepatic encephalopathy	MONDO:0010200		CHEBI:50503		1
28433104	Treatment		TREATS	HP:0002480	hepatic encephalopathy	MONDO:0010200		nonresorbable antibiotics		1
28433104	MAXO:0001175	liver transplantation	TREATS	Decompensated liver cirrhosis		MONDO:0010200				1
33197948	drug prescriptions		TREATS	hepatic form		MONDO:0010200	with Trientine	CHEBI:39501		1
33197948	drug prescriptions		TREATS	hepatic form		MONDO:0010200	with Trientintetrahydrochlorid	Trientintetrahydrochlorid		1
33197948	drug prescriptions		TREATS	hepatic form		MONDO:0010200	with D-Penicillamin	D-Penicillamin	hepatic form	1
33197948	drug prescriptions		TREATS	hepatic form		MONDO:0010200	with Zinc acetate	CHEBI:62984		1
33197948	drug prescriptions		TREATS	hepatic form		MONDO:0010200	with Zinc	CHEBI:27363		1
33197948	human genetic diagnostic		PREVENTS	misdiagnosis		Wilson Disease				1
31898387	transient elastography		TREATS	liver stiffness		Wilson disease		transient elastography		1
31898387	MAXO:0000376	Liver biopsy	TREATS	liver stiffness		MONDO:0010200				1
31898387	APRI score evaluation		TREATS	liver stiffness		Wilson disease		APRI score evaluation		1
31898387	FIB-4 score evaluation		TREATS	liver stiffness		MONDO:0010200		FIB-4 score evaluation		1
31898387	transient elastography (TE)		TREATS	HP:0001394	Cirrhosis	MONDO:0010200				1
31898387	APRI score evaluation		PREVENTS	HP:0001394	Cirrhosis	MONDO:0010200	with cut-off <1.5			1
31898387	FIB-4 score evaluation		PREVENTS	HP:0001394	Cirrhosis	MONDO:0010200	with cut-off <3.25			1
37184248	positron emission tomography (PET)		TREATS	diagnosis		MONDO:0010200		64-copper (64Cu)		1
32314442	MAXO:0001175	liver transplantation	TREATS	fulminant liver failure		MONDO:0010200				1
32314442	MAXO:0001175	liver transplantation	TREATS	Wilson disease						1
32314442	use of life support		TREATS	fulminant liver failure		MONDO:0010200				1
32314442	Kaplan-Meier analysis		PREVENTS	none		MONDO:0010200				1
32314442	Cox regression		PREVENTS	none		MONDO:0010200				1
34162411	cardiovascular magnetic resonance (CMR) study		TREATS	HP:0001685	myocardial fibrosis	MONDO:0010200				1
34162411	cardiovascular magnetic resonance (CMR) study		TREATS	reduced left ventricular global circumferential strain (LV-GCS)		MONDO:0010200				1
34439909	Diagnosis		TREATS	variable clinical course		MONDO:0010200		artificial neural network algorithms		1
34439909	Diagnosis		TREATS	HP:0003674	Onset	MONDO:0010200		artificial neural network algorithms		1
34439909	Diagnosis		TREATS	morbidity		MONDO:0010200	using	artificial neural network algorithms		1
34439909	Treatment		TREATS	HP:0001410	hepatic dysfunction	MONDO:0010200	with Glutamate	CHEBI:29987		1
34439909	Treatment		TREATS	HP:0001410	hepatic dysfunction	MONDO:0010200	with Asparagine	CHEBI:22653		1
34439909	Treatment		TREATS	HP:0001410	hepatic dysfunction	MONDO:0010200	with Taurine	CHEBI:15891		1
36096368	MAXO:0001175	liver transplantation	TREATS	HP:0004448	fulminant hepatic failure	MONDO:0010200	null	null	null	1
36096368	chelation therapy		TREATS	chronic liver disease		Wilson Disease		chelation		1
36096368	Sequencing		PREVENTS	progressive liver disease		Wilson Disease		ATP7B		1
31416725	positron emission tomographic techniques		PREVENTS	Neurodegenerative disease progression		Pediatric Neurodegenerative Disorders		molecular neuroimaging		1
31416725	management of neurodegenerative disorders		TREATS	Neurodegenerative disease progression		Pediatric Neurodegenerative Disorders		glucose metabolism positron emission tomographic scans		1
29528784	Treatment		TREATS	Wilson disease				CHEBI:50868		1
29528784	Immunosuppressants		PREVENTS	flare-ups of Lupus Nephritis		Lupus Nephritis		Immunosuppressants		1
29528784	Urinalysis		DETECTS	haematuria		MONDO:0005556				1
29528784	Evaluation for chronic liver disease		IDENTIFIES	Wilson disease						1
29528784	Pre-renal biopsy work-up		PREPARES FOR	diagnosing Lupus Nephritis		MONDO:0005556				1
30558096	administration		TREATS	HP:0001337	Tremor	MONDO:0010200	Sodium dimercaptopropanesulfonate	CHEBI:888		1
30558096	treatment		TREATS	hepatic symptoms		MONDO:0010200		CHEBI:7959		1
30558096	treatment		PREVENTS	further accumulation of copper		MONDO:0010200		CHEBI:35176		1
30936772	diagnostic evaluation		TREATS	progressive movement disorder		Neurologic Wilson disease				1
30936772	diagnostic evaluation		TREATS	HP:0200032	Kayser-Fleischer rings	Neurologic Wilson disease				1
30936772	early treatment initiation		PREVENTS	copper toxicity		Neurologic Wilson disease	with copper removal	copper removal		1
30936772	extensive workup		TREATS	low serum copper		Neurologic Wilson disease				1
30936772	extensive workup		TREATS	low ceruloplasmin		Neurologic Wilson disease				1
30936772	extensive workup		TREATS	increased 24-hour urine copper		Neurologic Wilson disease				1
31474637	Administering copper-chelating agents		TREATS	copper accumulation		MONDO:0010200	with D-penicillamine	copper-chelating agents	copper accumulation	1
31474637	Administering copper-chelating agents		TREATS	copper accumulation		MONDO:0010200	with Trientine	copper-chelating agents		1
31474637	Administering zinc acetate		TREATS	copper accumulation		MONDO:0010200		CHEBI:62984	copper accumulation	1
31474637	Measurement		DIAGNOSES	Wilson disease				Hepatic copper content		1
31474637	ATP7B gene analysis		DIAGNOSES	Wilson disease						1
30701819	successful treatment of HCV infection		TREATS	recrudescence of the disease		MONDO:0010200		direct antiviral drugs		1
30701819	successful treatment of HCV infection		TREATS	decompensation of liver cirrhosis		MONDO:0010200		direct antiviral drugs		1
30701819	elimination of the virus		TREATS	recrudescence of the disease		Wilson disease		virus		1
30701819	adequate lifelong medical treatment		PREVENTS	recrudescence of the disease		MONDO:0010200				1
30701819	adequate lifelong medical treatment		PREVENTS	decompensation of liver cirrhosis		MONDO:0010200				1
28573989	anterior segment optical coherence tomography (AS-OCT)		TREATS	HP:0200032	Kayser-Fleischer rings	MONDO:0010200				1
28573989	naked eye examination using torch light		TREATS	HP:0200032	Kayser-Fleischer rings	MONDO:0010200				1
28573989	slit lamp biomicroscopy		TREATS	Kayser-Fleischer ring		Wilson disease		slit lamp biomicroscopy	Kayser-Fleischer ring	1
31083157	modified radical mastectomy		TREATS	HP:0032408	lump in breast	MONDO:0010200				1
31083157	MAXO:0000647	chemotherapy (with epirubicin, cyclophosphamide, docetaxel, paclitaxel)	TREATS	primary breast cancer		MONDO:0010200	with epirubicin	CHEBI:47898		1
31083157	MAXO:0000647	chemotherapy (with epirubicin, cyclophosphamide, docetaxel, paclitaxel)	TREATS	primary breast cancer		MONDO:0010200	with cyclophosphamide	CHEBI:4027		1
31083157	MAXO:0000647	chemotherapy (with epirubicin, cyclophosphamide, docetaxel, paclitaxel)	TREATS	primary breast cancer		MONDO:0010200	with docetaxel	CHEBI:4672		1
31083157	MAXO:0000647	chemotherapy (with epirubicin, cyclophosphamide, docetaxel, paclitaxel)	TREATS	primary breast cancer		MONDO:0010200	with paclitaxel	CHEBI:45863		1
33879678	MAXO:0000079	genetic counseling	PREVENTS	HP:0001392	Liver disease	MONDO:0010200				1
33879678	MAXO:0000079	genetic counseling	PREVENTS	neurological degeneration		MONDO:0010200				1
33879678	clinical diagnosis		TREATS	HP:0001392	Liver disease	MONDO:0010200				1
33879678	clinical diagnosis		TREATS	neurological degeneration		MONDO:0010200				1
33879678	prenatal diagnosis		PREVENTS	HP:0001392	Liver disease	MONDO:0010200				1
33879678	prenatal diagnosis		PREVENTS	neurological degeneration		MONDO:0010200				1
34923539	Observation		TREATS	Reduced vision		Valsalva Retinopathy				1
34923539	Referral to a retinal specialist		TREATS	Bilateral subinternal limiting membrane macular hemorrhages		Valsalva Retinopathy				1
34923539	Ophthalmological examination		TREATS	Reduced vision		Valsalva Retinopathy				1
30384011	MAXO:0001298	therapy	TREATS	HP:0011967	Copper deficiency	MONDO:0010651		copper-histidine		1
30384011	MAXO:0001298	therapy	TREATS	HP:0011967	Copper deficiency	MONDO:0010651		CHEBI:38127		1
30384011	MAXO:0001298	therapy	TREATS	HP:0011967	Copper deficiency	MONDO:0010651		CHEBI:25548		1
30384011	MAXO:0001298	therapy	TREATS	HP:0011967	Copper deficiency	MONDO:0010651		CHEBI:16494		1
30384011	Combination therapy		TREATS	symptoms of copper toxicity		MONDO:0010200		CHEBI:39501	with dimercaptosuccinate	1
30384011	Use of brain shuttle		TREATS	symptoms		MONDO:0010200		CHEBI:30703	copper toxicity	1
30384011	Use of brain shuttle		TREATS	symptoms of copper toxicity		MONDO:0010200		CHEBI:30313		1
30384011	copper removal or delivery		TREATS	copper overload		Menkes and Wilson diseases	New	chelating principles	copper overload	1
35042319	MAXO:0000127	genetic testing	PREVENTS	misdiagnosis		MONDO:0010200				1
35042319	Liver transplantation		TREATS	liver failure		MONDO:0010200				1
35042319	Treatment		TREATS	copper accumulation		MONDO:0010200		CHEBI:38161	copper accumulation	1
35042319	Treatment		PREVENTS	copper accumulation		MONDO:0010200		CHEBI:38161		1
32281751	Administration of small doses of antiepileptic drugs		TREATS	generalized epilepsy		MONDO:0010200	small doses	antiepileptic drugs		1
32281751	Copper-chelation therapy		TREATS	HP:0001250	Seizures	MONDO:0010200		Copper-chelation therapy		1
32281751	Brain MRI		PREVENTS	generalized epilepsy		MONDO:0010200				1
28452067	monotherapy		TREATS	elevated aspartate aminotransferase		MONDO:0010200		CHEBI:27363		1
28452067	monotherapy		TREATS	elevated alanine aminotransferase		MONDO:0010200		CHEBI:27363		1
28452067	Zinc monotherapy		TREATS	elevated gamma-glutamyltransferase		MONDO:0010200		Zinc monotherapy		1
28452067	monotherapy		TREATS	increased 24-hour urinary copper		MONDO:0010200		CHEBI:27363		1
28452067	Maintaining normal transaminase values		TREATS	elevated aspartate aminotransferase		MONDO:0010200				1
28452067	Maintaining normal transaminase values		TREATS	elevated alanine aminotransferase		MONDO:0010200				1
28452067	Monitoring 24-hour urinary copper excretion		TREATS	increased 24-hour urinary copper		MONDO:0010200				1
38306527	Chelation therapy		TREATS	HP:0001337	Tremor	MONDO:0010200				1
38306527	Chelation therapy		TREATS	HP:0001332	Dystonia	MONDO:0010200				1
38306527	Chelation therapy		TREATS	psychiatric manifestations		MONDO:0010200				1
38306527	Genetic analysis		CONFIRMS	primary diagnosis		Wilson disease				1
38306527	Regular monitoring		ADJUSTS	treatment		MONDO:0010200				1
38306527	MAXO:0000487	Clinical assessments	MONITOR	treatment efficacy		MONDO:0010200				1
33763932	antiviral therapy		TREATS	HBV infection		liver cirrhosis in young children		CHEBI:22587		1
33763932	logistic regression		PREVENTS	HBsAg loss		liver cirrhosis in young children				1
28433098	Diagnosis through biochemical tests including liver tests, serum ceruloplasmin, and basal 24-hour urinary copper excretion and genotype determination		PREVENTS	HP:0001392	Hepatic disease	MONDO:0010200				1
28433098	Oral chelation treatment		TREATS	HP:0001392	Hepatic disease	MONDO:0010200	Oral	chelation		1
28433098	MAXO:0010026	Zinc supplementation	PREVENTS	HP:0001392	Hepatic disease	MONDO:0010200		CHEBI:27363		1
28433098	Differentiation of Wilsonian fulminant hepatic failure from decompensated cirrhosis		TREATS	HP:0001392	Hepatic disease	MONDO:0010200				1
28433098	MAXO:0001175	liver transplantation	TREATS	HP:0001392	Hepatic disease	MONDO:0010200				1
